Drug-induced neutropenia

DRUGADVERS_NEUTROPENIA

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D70.82# 1 out of 7 registries used, show all original rules.	2622
4. Check minimum number of events None	2622
5. Include endpoints None	2622
6. Filter based on genotype QC (FinnGen only)	2622

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF5

NAME	DRUGADVERS_NEUTROPENIA
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D7082
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Drug-induced neutropenia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	12860	7872	4919
Only index persons	11777	7306	4471
Unadjusted period prevalence (%)
Whole population	0.19	0.23	0.14
Only index persons	0.23	0.27	0.17
Median age at first event (years)
Whole population	63.94	62.61	66.05
Only index persons	63.92	62.58	66.11

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2622	1672	950
Unadjusted period prevalence (%)	0.52	0.57	0.42
Median age at first event (years)	62.66	60.48	66.49

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2393: Matched controls
23932

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

WW500

NOMESCO Finland

Blood transfusion

22.7

323.0

595

344

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

19.4

323.0

579

388

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

23.1

323.0

767

478

A49.9

ICD-10 Finland

Bacterial infection, unspecified

19.9

323.0

1205

1158

L03AA13

ATC

pegfilgrastim; parenteral

26.4

323.0

792

440

A04AA02

ATC

granisetron; systemic, transdermal

20.1

323.0

920

720

R50.9

ICD-10 Finland

Fever, unspecified

9.1

323.0

1016

1802

A03FA01

ATC

metoclopramide; systemic, rectal

16.0

323.0

1708

3231

JN4BD

NOMESCO Finland

Extensive body CT

8.8

323.0

903

1534

H02AB02

ATC

dexamethasone; systemic

24.1

323.0

1414

1350

115

Kela drug reimbursment

Breast cancer

9.5

323.0

772

1138

D70.82

ICD-10 Finland

Drug-induced neutropenia

+∞

323.0

2393

L03AA14

ATC

lipegfilgrastim; parenteral

30.6

320.3

436

173

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

15.9

309.3

530

420

L03AA02

ATC

filgrastim; parenteral

21.7

309.0

468

265

ZX120

NOMESCO Finland

Intravenous

7.9

277.5

717

1226

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

23.4

270.9

399

203

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

11.4

260.6

525

578

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

4.6

259.5

1395

5602

A04AA01

ATC

ondansetron; systemic, rectal

9.3

258.5

589

812

N02AA05

ATC

oxycodone; systemic

6.1

253.5

817

1865

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.1

226.5

1574

7637

XW000

NOMESCO Finland

Bone marrow biopsy

12.8

222.2

416

386

JN4AD

NOMESCO Finland

Body CT examination

7.5

222.1

581

976

XX3DW

NOMESCO Finland

Time consuming IT work

6.3

219.2

666

1374

J01MA12

ATC

levofloxacin; systemic

4.8

212.2

879

2582

A04AD12

ATC

aprepitant; systemic

16.7

203.5

337

232

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

28.3

202.9

281

112

A04AA55

ATC

palonosetron, combinations; systemic

13.2

196.6

361

317

Z51.5

ICD-10 Finland

Palliative care

9.2

195.1

439

571

HA1AA

NOMESCO Finland

X-ray mammography

6.5

191.2

555

1058

D70.89

ICD-10 Finland

Neutropenic splenomegaly

38.3

191.1

245

130

Kela drug reimbursment

Malignant tumour

6.8

185.2

520

944

L02BG04

ATC

letrozole; oral

7.2

181.9

485

817

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

10.4

181.2

376

420

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

6.9

179.4

496

878

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

10.1

177.6

375

432

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

20.4

173.5

266

146

WF049

NOMESCO Finland

Radiotherapy of metastasis

12.4

168.8

319

294

HAC20

NOMESCO Finland

Total mastectomy

8.8

167.2

383

506

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

28.1

166.1

230

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

10.7

157.9

322

344

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

20.5

155.9

238

128

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

6.5

152.2

434

788

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

6.9

152.2

414

705

TPX10

NOMESCO Finland

Implantation of vascular injection port

11.9

151.6

291

275

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

7.4

143.1

369

579

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.1

141.1

1160

5574

L02BA01

ATC

tamoxifen; oral

8.1

140.5

337

473

WZC30

NOMESCO Finland

Teaching

4.1

139.2

639

1943

A41.9

ICD-10 Finland

Sepsis, unspecified

10.5

135.3

277

295

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

34.2

133.2

175

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

8.5

131.9

305

402

PJA12

NOMESCO Finland

Sentinel node biopsy

4.9

128.5

473

1147

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

20.4

121.3

185

B01AB10

ATC

tinzaparin; parenteral

5.2

115.1

390

856

ZX112

NOMESCO Finland

Subcutaneous

11.7

114.8

221

207

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

6.1

113.4

334

619

L01BC06

ATC

capecitabine; oral

8.1

112.7

268

366

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.6

111.4

590

1978

M04AA01

ATC

allopurinol; systemic

4.0

110.3

502

1478

WF003

NOMESCO Finland

Adjuvant radiotherapy

7.7

108.9

267

382

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

9.9

107.5

226

250

D64.9

ICD-10 Finland

Anaemia, unspecified

4.5

107.5

423

1083

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

5.7

106.4

334

667

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

24.9

105.1

150

D69.5

ICD-10 Finland

Secondary thrombocytopenia

82.1

104.2

117

ZX070

NOMESCO Finland

Intensity modified radiotherapy

12.4

104.1

194

169

ZX080

NOMESCO Finland

Image guided radiotherapy

11.2

103.4

203

197

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

15.1

103.3

176

125

B01AB05

ATC

enoxaparin; parenteral

2.6

95.4

988

5100

A02BC02

ATC

pantoprazole; systemic

2.6

92.9

1774

12618

X76

ICPC

Malignant neoplasm breast female

10.7

92.4

185

186

JN6AD

NOMESCO Finland

CT of torso and neck

15.8

91.6

153

103

JN4CD

NOMESCO Finland

Very extensive body CT

6.5

91.1

252

425

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.8

89.5

710

3103

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

17.3

86.4

139

NK6AN

NOMESCO Finland

Total body bone isotope imaging

7.6

85.2

210

300

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.2

81.0

487

1752

C50.99

ICD-10 Finland

Breast, unspecified

7.1

78.8

203

309

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.8

78.5

281

641

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

77.9

670

3033

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

4.2

76.3

322

864

WW300

NOMESCO Finland

Transfer of autologic stem cells

50.3

76.2

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

11.2

75.6

147

139

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

7.7

73.5

179

250

H02AB06

ATC

prednisolone; systemic

2.2

71.6

1277

8239

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

11.4

71.6

138

128

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.9

70.3

318

905

C83.1

ICD-10 Finland

Mantle cell lymphoma

32.2

70.1

J01MA14

ATC

moxifloxacin; systemic

3.6

69.8

352

1097

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

8.1

69.4

163

215

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

5.2

68.9

227

471

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

8.6

68.8

155

191

L02BG06

ATC

exemestane; oral

10.7

68.4

136

134

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

16.3

68.2

112

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

6.8

67.7

178

278

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

12.5

66.5

122

102

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.6

66.3

250

598

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

10.4

65.4

132

134

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

10.4

63.6

128

129

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.4

63.4

659

3249

M05BX04

ATC

denosumab; parenteral

4.5

63.3

242

586

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

9.1

62.5

136

158

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

7.6

62.3

151

209

128

Kela drug reimbursment

Cancers of female genital organs

8.7

61.2

136

164

1CD02

NOMESCO Finland

14.0

60.8

106

L01CB01

ATC

etoposide; systemic

28.2

59.9

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

5.6

59.3

181

342

TGC00

NOMESCO Finland

Bronchial lavation

6.7

59.1

157

248

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

9.3

58.9

126

142

L01CA04

ATC

vinorelbine; systemic

16.1

58.4

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.5

58.4

305

970

HAB40

NOMESCO Finland

Wedge excision of mammary gland

3.9

58.2

263

742

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

5.3

58.0

187

377

YNB10

NOMESCO Finland

Collection of stem cells for transplant

92.4

57.1

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

11.6

56.9

108

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

11.6

56.9

108

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

6.9

56.6

147

225

PJA10

NOMESCO Finland

Exploration of lymph nodes

11.0

56.5

110

104

WF004

NOMESCO Finland

Palliative radiotherapy

8.1

56.3

131

170

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

6.6

54.8

147

235

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

6.2

53.7

151

257

N02BE01

ATC

paracetamol; systemic, rectal

2.6

53.0

2136

18288

C03CA01

ATC

furosemide; systemic

2.1

51.3

702

3874

J01DB01

ATC

cefalexin; oral

2.2

50.0

2005

16732

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

19.6

49.9

TQW20

NOMESCO Finland

Tatoe

9.1

49.7

107

122

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

8.4

49.5

112

139

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.9

48.9

1287

9109

Z31.5

ICD-10 Finland

Genetic counselling

4.0

48.8

206

545

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.3

48.5

156

313

ZX108

NOMESCO Finland

Inhalation

17.8

48.2

C50

ICD-10 Finland

Malignant neoplasm of breast

6.0

47.2

135

235

ZX090

NOMESCO Finland

Other technic of radiotherapy

5.3

47.0

149

294

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.9

46.9

309

1151

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

8.1

46.7

108

139

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

8.4

46.5

105

130

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

45.4

980

6401

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.9

45.3

201

555

WF002

NOMESCO Finland

Radical radiotherapy

4.0

44.9

189

498

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.6

43.9

351

1467

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

43.8

743

4421

Z51.0

ICD-10 Finland

Radiotherapy session

8.9

43.8

110

J05AB11

ATC

valaciclovir; oral

2.5

43.8

395

1766

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

11.8

42.8

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

3.8

42.7

191

531

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

6.3

42.5

117

194

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.1

42.2

586

3207

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

7.5

42.1

102

141

N05AH02

ATC

clozapine; systemic

6.9

41.5

107

162

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

14.3

41.5

192

Kela drug reimbursment

Fulvestrant

15.9

41.5

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.0

40.7

256

920

WX402

NOMESCO Finland

General anaesthesia

2.2

40.6

476

2414

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

7.6

40.5

132

ZX121

NOMESCO Finland

Central venous catheter

26.0

40.3

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

6.5

40.1

107

170

AA1BD

NOMESCO Finland

Extensive CT of head and brain

5.2

40.1

130

263

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

33.2

39.8

N05CF01

ATC

zopiclone; oral

1.9

39.8

836

5336

A79

ICPC

Malignancy NOS

7.4

39.7

136

L02BA03

ATC

fulvestrant; parenteral

15.9

39.7

N05BA06

ATC

lorazepam; systemic, sublingual

3.6

39.5

187

545

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

6.9

39.4

101

152

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.3

39.1

207

658

N05AH03

ATC

olanzapine; systemic

3.4

39.0

205

648

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

5.0

38.9

130

272

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

12.2

38.7

B99

ICD-10 Finland

Other and unspecified infectious diseases

7.1

38.3

140

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.5

38.1

339

1496

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.4

38.1

198

621

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

6.5

37.5

100

159

FM1FN

NOMESCO Finland

Heart function isotope examination

16.0

37.4

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

5.1

37.2

122

250

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.6

37.1

288

1178

1501

Kela drug reimbursment

Palbociclib

14.3

37.0

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

5.9

36.9

106

186

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.8

36.4

254

975

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

4.9

36.2

123

262

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

21.6

36.2

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.6

35.9

286

1183

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

35.7

1021

7140

ED1AA

NOMESCO Finland

Mandipular X-ray examination

12.9

35.3

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

5.8

35.3

103

184

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

23.2

34.9

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

10.9

34.7

TPH07

NOMESCO Finland

Cathetrisation of artery

2.5

34.6

305

1337

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

11.1

34.5

A06AH03

ATC

naloxegol; oral

8.8

34.4

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

9.5

34.1

TGD00

NOMESCO Finland

Needle biopsy of lung

18.0

34.1

A41.8

ICD-10 Finland

Other specified sepsis

7.3

33.6

115

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

32.0

33.5

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

10.1

33.4

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

9.7

33.1

GD1AD

NOMESCO Finland

Thorax CT examination

3.5

33.0

162

485

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

9.8

32.9

B03XA02

ATC

darbepoetin alfa; parenteral

6.1

32.8

153

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

7.0

32.7

120

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

6.6

32.5

132

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

5.4

32.5

100

191

SPAT1255

SPAT

Intravenous administration of medicine

3.0

32.5

201

712

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

5.5

32.5

183

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

25.4

32.3

L02BG03

ATC

anastrozole; oral

5.7

32.3

172

A06AD11

ATC

lactulose; oral

2.2

32.1

356

1745

1XC02

NOMESCO Finland

9.5

31.9

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

12.1

31.7

C82.1

ICD-10 Finland

Follicular lymphoma grade II

10.4

30.9

ZXE20

NOMESCO Finland

More than three and less than five hours

2.1

30.7

374

1906

R11

ICD-10 Finland

Nausea and vomiting

2.7

30.5

226

896

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.1

30.3

177

600

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

5.7

30.3

161

JN3AD

NOMESCO Finland

Abdominal CT examination

2.6

30.1

237

974

L01XE33

ATC

[U] palbociclib; oral

15.6

29.9

394

Kela drug reimbursment

Palbociclib

12.9

29.9

ZXD05

NOMESCO Finland

Urgent procedure

1.7

29.8

745

4928

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.8

29.8

132

364

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

14.6

29.7

ZXE00

NOMESCO Finland

One hour or less

1.7

29.5

961

6863

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

15.3

29.1

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

10.6

28.7

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

5.2

28.6

177

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

7.3

28.4

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

21.9

28.3

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

3.6

28.1

132

382

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

8.0

27.9

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

6.9

27.7

104

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.5

27.4

229

969

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.0

27.2

166

581

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

27.1

710

4735

A46

ICD-10 Finland

Erysipelas

2.1

26.5

332

1708

TPX15

NOMESCO Finland

Removal of vascular injection port

15.6

26.4

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

23.5

26.1

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

5.1

25.9

171

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

7.7

25.6

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.8

25.5

111

302

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

25.3

363

1969

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

25.3

305

1540

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

8.9

25.3

9673/3-C42.1

ICD-O-3

Mantle cell lymphoma of bone marrow

36.0

25.2

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

20.9

25.2

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

11.4

25.1

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

25.1

997

7403

JAL30

NOMESCO Finland

Omentectomy

6.6

25.0

101

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

16.2

25.0

1XC03

NOMESCO Finland

17.2

24.9

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

8.1

24.7

B00.2

ICD-10 Finland

Herpesviral gingivostomatitis and pharyngotonsillitis

15.6

24.6

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

24.5

382

2138

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

24.5

684

4617

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

4.8

24.1

172

127

Kela drug reimbursment

Transplant complication

5.5

23.9

135

WW409

NOMESCO Finland

Other aferesis

22.3

23.0

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.6

23.0

181

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

8.0

23.0

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.2

23.0

223

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

7.1

22.9

XX1XN

NOMESCO Finland

Other isotope examination

7.7

22.8

ZX131

NOMESCO Finland

Intrathecal

84.3

22.7

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

121.2

22.6

R50.8

ICD-10 Finland

Other specified fever

12.7

22.6

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

5.4

22.6

132

L02BB04

ATC

enzalutamide; oral

9.2

22.5

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

15.0

22.5

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

6.8

22.4

ZZF00

NOMESCO Finland

Graft of adipose tissue

6.6

22.4

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.1

22.3

224

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

10.2

22.3

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

6.7

22.3

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

3.2

22.2

119

382

Z2446

NOMESCO Finland

Social worker

2.5

22.1

179

744

PJW99

NOMESCO Finland

Other operation on lymphatic system

10.9

22.1

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

4.9

21.7

151

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.8

21.6

110

L02AE02

ATC

leuprorelin; implant, parenteral

3.2

21.6

117

379

ZX095

NOMESCO Finland

Combined chemoradiotherapy

7.9

21.5

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

4.3

21.4

190

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

8.7

21.4

HAB99

NOMESCO Finland

Other partial excision of mammary gland

3.7

21.2

265

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

4.9

21.2

146

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

34.1

21.1

B02.9

ICD-10 Finland

Zoster without complication

2.6

21.1

162

653

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

24.4

20.8

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

14.2

20.8

3AA13

NOMESCO Finland

19.6

20.8

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.0

20.7

211

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.5

20.6

166

687

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

3.4

20.5

101

305

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

20.5

320

1785

N05AD01

ATC

haloperidol; systemic

3.7

20.5

258

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.4

20.4

102

311

A07AA09

ATC

vancomycin; oral

6.2

20.3

KFC00

NOMESCO Finland

Unilateral orchiectomy

11.7

20.2

212

Kela drug reimbursment

Gout

4.8

20.1

146

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

7.3

20.0

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

13.8

20.0

R18

ICD-10 Finland

Ascites

4.6

20.0

156

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

6.7

20.0

JAH00

NOMESCO Finland

Laparotomy

3.8

19.9

238

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

10.1

19.8

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.3

19.6

200

931

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

5.6

19.5

104

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

9.7

19.3

J05AB01

ATC

aciclovir; systemic

1.7

19.3

500

3272

D40.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Testis

11.8

19.3

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

8.1

19.2

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

46.4

19.2

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.8

19.2

226

WX110

NOMESCO Finland

Local anesthesy

1.5

19.1

1573

13430

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

5.2

19.1

115

163

Kela drug reimbursment

Abiraterone and enzalutamide

6.8

19.1

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

5.3

19.1

111

ZZR10

NOMESCO Finland

Flap of skin and muscle

6.6

19.0

A07AA02

ATC

nystatin; oral

2.3

19.0

176

785

L01EF01

ATC

palbociclib; oral

14.9

18.9

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

7.3

18.8

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

28.0

18.7

ZZQ70

NOMESCO Finland

Free microvascular graft of lymph nodes

70.4

18.7

D70.80

ICD-10 Finland

Agranulocytic angina

191.4

18.6

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

38.7

18.6

WW402

NOMESCO Finland

Leucoferesis

38.7

18.6

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.8

18.5

123

457

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

5.1

18.5

115

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.3

18.4

175

790

3AA02

NOMESCO Finland

44.3

18.2

R06AE07

ATC

cetirizine; oral

1.5

18.2

984

7661

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

9.9

18.1

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.0

18.1

236

1226

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

18.1

126

480

B72

ICPC

Hodgkin Lymphoma

33.2

18.0

L04AA06

ATC

mycophenolic acid; systemic

4.5

17.9

146

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

7.0

17.9

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

6.4

17.9

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

6.4

17.9

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

17.9

202

987

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.6

17.8

235

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

18.2

17.8

WW200

NOMESCO Finland

Immunization

3.4

17.6

264

JAH01

NOMESCO Finland

Laparoscopy

2.7

17.6

120

452

A28

ICPC

Limited function/disability NOS

1.8

17.6

309

1791

Z3231

NOMESCO Finland

Registered nurse

1.6

17.5

627

4443

XX1AD

NOMESCO Finland

Other CT-examination

8.4

17.5

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

12.1

17.3

TJA10

NOMESCO Finland

Laparocentesis

21.0

17.3

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

14.0

17.3

N02AA01

ATC

morphine; systemic, rectal

6.0

17.2

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

8.9

17.2

J01MA02

ATC

ciprofloxacin; systemic

1.5

17.0

862

6592

C83.00

ICD-10 Finland

Lymphocytic lymphoma

16.1

17.0

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

4.0

16.9

169

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.2

16.9

289

SPAT1109

SPAT

Analgesia with portable analgesic pump

9.6

16.9

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

4.5

16.8

133

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.4

16.7

141

598

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

9.8

16.6

N02AX02

ATC

tramadol; systemic, rectal

1.5

16.5

947

7415

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.8

16.5

193

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

10.1

16.4

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

6.1

16.4

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

5.9

16.3

HAE99

NOMESCO Finland

Other reconstruction of breast

5.8

16.3

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

10.5

16.2

H02AB09

ATC

hydrocortisone; systemic

3.6

16.1

202

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

16.8

16.1

PG1BD

NOMESCO Finland

Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft

47.8

16.0

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

5.6

16.0

SPAT1254

SPAT

Administration of medicine

1.8

15.8

306

1827

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.8

15.8

101

366

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.4

15.8

1370

390

Kela drug reimbursment

Ibrutinib

33.6

15.7

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

15.8

15.7

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

8.8

15.7

N05BA04

ATC

oxazepam; oral

1.5

15.7

557

3922

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

9.3

15.7

R4110

NOMESCO Finland

Physiotherapy

1.5

15.7

608

4372

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.3

15.6

240

WE300

NOMESCO Finland

Profylactive therapy of malignancy with biomoidiers

85.6

15.6

JAL00

NOMESCO Finland

Biopsy of peritoneum

7.9

15.6

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

15.5

153

706

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

15.4

322

1968

188

Kela drug reimbursment

Psychosis requiring demanding treatment

5.1

15.3

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

10.5

15.2

L01BC59

ATC

trifluridine, combinations; systemic

28.8

15.2

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

20.2

15.1

5BA08

NOMESCO Finland

7.8

15.1

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

6.4

15.0

TQB05

NOMESCO Finland

Puncture of skin of trunk

6.4

15.0

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.9

15.0

159

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

15.1

14.9

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.0

14.8

288

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

14.8

250

1427

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

3.4

14.7

218

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

18.5

14.7

L01BB05

ATC

fludarabine; systemic

25.2

14.7

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

11.9

14.6

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.5

14.5

169

2924

L02BX03

ATC

abiraterone; oral

8.9

14.4

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

6.6

14.3

E0000UV

ATC

1.4

14.2

850

6652

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

10.5

14.2

ZY010

NOMESCO Finland

Hospital outpatient

2.4

14.1

120

514

JFB00

NOMESCO Finland

Partial resection of small intestine

4.4

14.1

115

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

5.0

14.0

N04AA02

ATC

biperiden; systemic

3.5

13.9

185

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.5

13.8

111

460

B01AB04

ATC

dalteparin; parenteral

2.3

13.8

126

559

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

13.7

364

2377

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

9.1

13.7

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

4.1

13.6

133

RS220

NOMESCO Finland

4.5

13.6

105

A40.8

ICD-10 Finland

Other streptococcal sepsis

5.9

13.6

GEA00

NOMESCO Finland

Mediastinoscopy

12.1

13.6

N03AX16

ATC

pregabalin; oral

1.5

13.6

528

3781

X21

ICPC

Breast sympt/compl female other

3.5

13.5

179

WF099

NOMESCO Finland

Other radiotherapy

8.8

13.5

PJ1AN

NOMESCO Finland

Lymphsystem isotope imaging

16.3

13.4

A02BC01

ATC

omeprazole; systemic

1.5

13.3

595

4385

J94.8

ICD-10 Finland

Other specified pleural conditions

4.1

13.3

126

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

4.7

13.3

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

5.4

13.3

C90.0

ICD-10 Finland

Multiple myeloma

5.8

13.3

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

4.1

13.2

127

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

7.3

13.2

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

6.1

13.2

ZX100

NOMESCO Finland

Oral

4.1

13.2

123

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

6.9

13.1

L02AE03

ATC

goserelin; implant

4.6

13.1

100

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

6.5

13.1

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

11.0

13.0

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

4.4

13.0

106

L04AX01

ATC

azathioprine; systemic

2.4

12.9

108

457

UJF32

NOMESCO Finland

Coloscopy

1.5

12.9

575

4232

9680/3-C71.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of brain, NOS

50.3

12.8

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

5.5

12.8

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.6

12.8

367

WX702

NOMESCO Finland

Supraglottic ventilation device

2.2

12.8

134

635

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

5.0

12.8

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

5.0

12.8

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.5

12.7

398

N05AH04

ATC

quetiapine; oral

1.6

12.7

335

2181

RD211

NOMESCO Finland

2.3

12.7

113

495

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.0

12.7

158

806

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.3

12.5

186

SPAT1088

SPAT

Blood transfusion

8.7

12.5

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

8.7

12.5

R84

ICPC

Malignant neoplasm bronchus/lung

10.1

12.5

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

7.3

12.5

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.9

12.4

254

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

7.6

12.4

TAB00

NOMESCO Finland

Lumbar puncture

2.4

12.4

106

458

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

4.3

12.3

107

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

8.0

12.3

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

11.7

12.3

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.1

12.3

216

ZX050

NOMESCO Finland

Stereotactic radiotherapy

6.4

12.1

1512

Kela drug reimbursment

Ibrutinib

26.8

12.0

S18

ICPC

Laceration/cut

1.4

12.0

918

7448

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

7.6

11.9

N06AX16

ATC

venlafaxine; oral

1.6

11.9

302

1947

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

8.0

11.8

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

4.2

11.8

107

C34.86

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary microcellular carcinoma

14.7

11.8

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

11.7

752

5912

N63

ICD-10 Finland

Unspecified lump in breast

2.0

11.7

145

740

SPAT1153

SPAT

Removal of sutures

1.4

11.7

714

5565

HAD99

NOMESCO Finland

Other plastic operation on breast

6.3

11.7

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.4

11.7

419

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

16.5

11.7

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.2

11.6

191

L01XE27

ATC

[U] ibrutinib; oral

30.2

11.6

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

4.7

11.6

JN5AN

NOMESCO Finland

Total body isotope imaging

65.3

11.6

XX9CD

NOMESCO Finland

Very extensive complementary CT

19.0

11.6

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

7.2

11.5

C84.49

ICD-10 Finland

Peripheral T-cell lymphoma, unspecified cell type

+∞

11.5

L01AA02

ATC

chlorambucil; oral

13.7

11.4

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.5

11.4

360

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.3

11.4

167

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.6

11.4

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

6.4

11.4

C50.39

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology

11.9

11.3

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

11.3

168

919

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

11.3

276

1759

9663/3-C77.9

ICD-O-3

Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS

35.2

11.3

C81.2

ICD-10 Finland

Mixed cellularity classical Hodgkin lymphoma

35.2

11.3

JFF10

NOMESCO Finland

Loop enterostomy

7.3

11.2

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

5.9

11.2

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.3

11.1

100

442

C81.7

ICD-10 Finland

Other classical Hodgkin lymphoma

25.1

11.1

191

Kela drug reimbursment

Erlotinib

25.1

11.1

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

11.0

148

778

P01AB01

ATC

metronidazole; oral, rectal

1.4

11.0

874

7105

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

10.1

11.0

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

10.1

11.0

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.1

11.0

121

585

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

3.7

11.0

125

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

4.6

11.0

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.0

10.9

132

665

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

5.5

10.9

SPAT1263

SPAT

Sampling

1.4

10.9

907

7432

C56

ICD-10 Finland

Malignant neoplasm of ovary

8.3

10.8

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

10.6

10.8

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

7.2

10.7

8461/3-C57.0

ICD-O-3

High grade serous carcinoma of fallopian tube

17.9

10.7

369

Kela drug reimbursment

Regorafenib

21.5

10.7

L04AD01

ATC

ciclosporin; systemic

3.1

10.7

187

N05AA01

ATC

chlorpromazine; systemic, rectal

3.8

10.7

118

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

6.7

10.7

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

6.7

10.7

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

7.6

10.7

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

12.9

10.6

9680/3-C42.1

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of bone marrow

60.3

10.6

J01FF01

ATC

clindamycin; systemic

1.4

10.6

570

4327

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

5.1

10.6

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.8

10.6

245

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.4

10.5

376

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

3.4

10.5

145

A05AA02

ATC

ursodeoxycholic acid; oral

3.5

10.5

135

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

14.3

10.5

J02AC03

ATC

voriconazole; systemic

14.3

10.5

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

10.5

145

770

D70

ICD-10 Finland

Agranulocytosis

110.5

10.4

C83.71

ICD-10 Finland

Burkitt's tumour

110.5

10.4

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

5.9

10.4

N05AA02

ATC

levomepromazine; systemic

2.2

10.4

100

458

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

16.1

10.3

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

12.1

10.3

C62.12

ICD-10 Finland

Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma

32.7

10.3

C83.89

ICD-10 Finland

Other types of diffuse non-Hodgkin's lymphoma

32.7

10.3

ZYC01

NOMESCO Finland

Remote contact by phone

2.2

10.3

103

481

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

7.1

10.3

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

5.5

10.3

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

9.6

10.2

Z51.3

ICD-10 Finland

Blood transfusion (without reported diagnosis)

23.5

10.2

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.0

10.2

125

635

AA1AD

NOMESCO Finland

CT of head and brain

1.4

10.1

487

3614

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.5

10.1

319

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

6.9

10.1

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

2.0

10.1

130

674

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

10.1

840

6862

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

6.5

10.0

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

6.5

10.0

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

9.2

10.0

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

14.6

10.0

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

10.0

164

926

JAH21

NOMESCO Finland

Staging laparoscopy

40.2

10.0

N05AN01

ATC

lithium; oral

2.8

9.9

224

F20.10

ICD-10 Finland

Raise schizophrenia continuously

7.6

9.9

A02BC05

ATC

esomeprazole; systemic

1.3

9.9

877

7225

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

12.2

9.8

D47.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified

12.2

9.8

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

5.4

9.8

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

2.8

9.8

227

HA1BA

NOMESCO Finland

Extensive X-ray mammography

5.7

9.8

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

5.7

9.8

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

20.1

9.8

T80.8

ICD-10 Finland

Other complications following infusion, transfusion and therapeutic injection

20.1

9.8

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

7.0

9.8

1CD01

NOMESCO Finland

10.7

9.8

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

4.8

9.8

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

9.7

171

987

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.7

9.7

113

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

7.4

9.7

N05AX12

ATC

aripiprazole; systemic

2.3

9.7

373

9680/3-C16.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of stomach, NOS

55.2

9.6

D61.1

ICD-10 Finland

Drug-induced aplastic anaemia

55.2

9.6

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

5.6

9.6

B34.9

ICD-10 Finland

Viral infection, unspecified

2.8

9.6

216

N05AF05

ATC

zuclopenthixol; systemic

3.9

9.6

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.7

9.6

241

A03

ICPC

Fever

1.5

9.5

298

2020

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

10.1

9.5

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.8

9.5

105

J02AC01

ATC

fluconazole; systemic

1.3

9.5

872

7210

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

6.6

9.4

9698/3-C77.8

ICD-O-3

Follicular lymphoma, grade 3 of lymph nodes of multiple regions

100.4

9.4

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

6.2

9.4

352

Kela drug reimbursment

Abiraterone and enzalutamide

5.3

9.4

WC115

NOMESCO Finland

Cytostatic therapy of local tumor recidive with multiple drugs

21.8

9.3

1AA09

NOMESCO Finland

21.8

9.3

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.6

9.3

265

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

9.5

9.3

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

6.0

9.2

C20

ICD-10 Finland

Malignant neoplasm of rectum

6.0

9.2

I88.9

ICD-10 Finland

Nonspecific lymphadenitis, unspecified

7.3

9.2

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.3

9.2

344

R4190

NOMESCO Finland

Nutritional therapy

2.4

9.1

318

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

2.4

9.1

338

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

8.3

9.1

J01CA04

ATC

amoxicillin; systemic

1.3

9.1

1773

16285

C34.96

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary microcellular carcinoma

36.8

9.0

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

10.1

9.0

A04AA03

ATC

tropisetron; systemic

10.1

9.0

P72

ICPC

Schizophrenia

3.1

9.0

148

ZXA05

NOMESCO Finland

Left side

1.4

9.0

526

4043

TQW99

NOMESCO Finland

Other minor procedure on skin

2.0

9.0

107

540

WNF00

NOMESCO Finland

Infection source and contact determination

6.1

8.9

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

24.1

8.9

E83.50

ICD-10 Finland

Hypercalcemia

3.7

8.8

102

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

5.9

8.7

L02AB02

ATC

medroxyprogesterone; systemic (progestogens)

5.6

8.7

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.9

8.7

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.1

8.7

146

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

4.2

8.7

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

4.9

8.7

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

7.7

8.6

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

4.6

8.6

HAD40

NOMESCO Finland

Mastopexy

5.8

8.6

V03AF03

ATC

calcium folinate; systemic

16.3

8.5

N05AL05

ATC

amisulpride; oral

16.3

8.5

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

6.9

8.5

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

6.9

8.5

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

6.9

8.5

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

8.5

120

644

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

8.5

780

6419

372

Kela drug reimbursment

Idelalisib

90.4

8.4

NF3AA

NOMESCO Finland

Femur X-ray examination

2.9

8.4

165

SPAT1290

SPAT

Preparation of deceased person

12.8

8.4

L01AA01

ATC

cyclophosphamide; systemic

7.9

8.4

SPAT1269

SPAT

Other puncture and/or drainage

4.5

8.3

N06DX01

ATC

memantine; oral

0.2

8.3

419

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

8.3

119

644

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

8.6

8.3

D75

ICPC

Malignant neoplasm colon/rectum

5.3

8.3

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

10.8

8.3

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

4.0

8.2

N05AX08

ATC

risperidone; systemic

1.8

8.2

142

818

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

4.5

8.2

ECB20

NOMESCO Finland

Oral alveoplasty

4.1

8.2

GD6AD

NOMESCO Finland

CT of chest and neck

7.5

8.2

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

7.5

8.2

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

6.0

8.1

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

6.0

8.1

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

5.4

8.1

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.7

8.1

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.7

8.1

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

33.5

8.1

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.7

8.1

201

C34.36

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma

11.7

8.1

ZX114

NOMESCO Finland

Intramuscular

3.1

8.1

132

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

2.5

8.1

254

X77

ICPC

Malignant neopl genital female other

6.8

8.1

L01XE03

ATC

[U] erlotinib; oral

22.1

8.0

D70.81

ICD-10 Finland

Neutropenia congenital

22.1

8.0

N06AX11

ATC

mirtazapine; oral

1.3

8.0

646

5213

HA1HA

NOMESCO Finland

Tomosynthesis mammography

5.3

8.0

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

5.9

8.0

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

5.5

8.0

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.0

8.0

493

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

7.2

8.0

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

7.2

8.0

B37.08

ICD-10 Finland

Other candidal stomatitis

4.4

7.9

QBJ00

NOMESCO Finland

Liposuction in trunk

5.1

7.8

SPAT1229

SPAT

Assessment of need for aid

1.7

7.8

164

1001

116

Kela drug reimbursment

Prostate cancer

2.0

7.8

463

ZXA00

NOMESCO Finland

Right side

1.3

7.8

551

4352

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

3.1

7.8

130

X19

ICPC

Breast lump/mass female

3.1

7.8

130

R60.0

ICD-10 Finland

Localized oedema

1.6

7.8

217

1428

Z94.2

ICD-10 Finland

Lung transplant status

10.8

7.8

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

10.8

7.8

-50

ICPC

Medication/prescr/renewal

2.1

7.8

442

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.6

7.8

211

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

4.8

7.8

9680/3-C80.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of unknown primary site

45.1

7.7

C62.11

ICD-10 Finland

Malignant tumor of the descending testicle, seminoma

15.1

7.7

K12.10

ICD-10 Finland

Stomatitis NOS

5.3

7.7

PJD63

NOMESCO Finland

Laparoscopic dissection of aortic lymph nodes

5.3

7.7

SPAT1301

SPAT

No procedures

1.3

7.7

650

5274

N03AG01

ATC

valproic acid; systemic, rectal

1.8

7.6

124

700

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

4.7

7.6

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.5

7.6

233

AAA10

NOMESCO Finland

Biopsy through craniotomy

18.4

7.6

1XC07

NOMESCO Finland

8.0

7.6

C54.21

ICD-10 Finland

Leiomyosarcoma and myometrium

11.9

7.6

C84.51

ICD-10 Finland

Other and unspecified T-cell lymphomas

25.1

7.6

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.6

7.6

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

3.9

7.5

2951C

ICD-9 Finland

Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN]

8.9

7.5

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.5

7.5

A98

ICPC

Health maint/preventive medicine

0.7

7.5

2111

21937

A07EA06

ATC

budesonide; oral, local oral

2.2

7.4

320

C62.10

ICD-10 Finland

Malignant tumor of the descending testicle, no histological verification

80.3

7.4

9652/3-C77.9

ICD-O-3

Hodgkin lymphoma, mixed cellularity, NOS, of lymph node, NOS

80.3

7.4

E87.6

ICD-10 Finland

Hypokalaemia

2.3

7.4

301

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

7.4

171

1073

C81.0

ICD-10 Finland

Nodular lymphocyte predominant Hodgkin lymphoma

13.4

7.4

C95.0

ICD-10 Finland

Acute leukaemia of unspecified cell type

13.4

7.4

L01BC53

ATC

tegafur, combinations; systemic

13.4

7.4

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.1

7.4

119

K56.7

ICD-10 Finland

Ileus, unspecified

3.1

7.4

119

N17.8

ICD-10 Finland

Other acute renal failure

3.7

7.3

L02BB03

ATC

bicalutamide; oral

2.6

7.3

189

R06.0

ICD-10 Finland

Dyspnoea

1.3

7.3

493

3863

1BC01

NOMESCO Finland

+∞

7.3

WPB10

NOMESCO Finland

Making a convalescent care decision

+∞

7.3

L01XX47

ATC

[U] idelalisib; oral

+∞

7.3

F20.1

ICD-10 Finland

Hebephrenic schizophrenia

10.9

7.3

Z43.3

ICD-10 Finland

Attention to colostomy

9.4

7.3

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

7.3

339

ZXC40

NOMESCO Finland

Use of ultrasound

4.5

7.3

NE1DG

NOMESCO Finland

Pelvic, hip and femur very extensive MRI examination with high intensity magnet

5.2

7.2

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

5.2

7.2

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

6.2

7.2

Z80.4

ICD-10 Finland

Family history of malignant neoplasm of genital organs

6.2

7.2

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

7.2

196

1284

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

15.8

7.2

HAC25

NOMESCO Finland

Radical mastectomy

7.3

7.2

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

30.1

7.1

C83.33

ICD-10 Finland

Primary medical lymphoma with large B cells

30.1

7.1

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

30.1

7.1

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

2.9

7.1

142

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

20.1

7.1

C84.59

ICD-10 Finland

Other and unspecified T-cell lymphomas

20.1

7.1

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

7.1

761

6365

Y83.4

ICD-10 Finland

Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

12.1

7.1

1CX01

NOMESCO Finland

12.1

7.1

A07EC01

ATC

sulfasalazine; oral, rectal

1.6

7.0

166

1049

159

Kela drug reimbursment

Pazopanib

10.0

7.0

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

10.0

7.0

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

3.4

7.0

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

7.0

122

706

SPAT1262

SPAT

Handing over of treatment supplies

1.4

7.0

361

2705

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

4.9

7.0

TK800

NOMESCO Finland

Hemodialysis

2.6

7.0

194

X26

ICPC

Fear of breast cancer female

4.5

6.9

QBA00

NOMESCO Finland

Puncture of skin of trunk

5.2

6.9

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.9

6.9

521

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

6.9

232

1596

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

6.9

339

2516

WW306

NOMESCO Finland

Transfer of stem cells from foreign registered donator

13.8

6.9

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

6.9

425

3281

RF210

NOMESCO Finland

2.3

6.9

273

UDC00

NOMESCO Finland

Ear microscopy

1.7

6.8

140

853

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

4.8

6.8

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.7

6.8

155

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

8.3

6.8

6BA02

NOMESCO Finland

8.3

6.8

WX720

NOMESCO Finland

Own respiration

2.1

6.8

368

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

4.5

6.8

J70.4

ICD-10 Finland

Drug-induced interstitial lung disorders, unspecified

40.2

6.8

9680/3-C09.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of tonsil, NOS

40.2

6.8

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

6.7

346

2589

1XX32

NOMESCO Finland

16.7

6.7

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.0

6.7

116

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.8

6.7

144

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.2

6.7

369

R53

ICD-10 Finland

Malaise and fatigue

1.4

6.7

376

2857

9085/3-C62.9

ICD-O-3

Mixed germ cell tumor of testis, NOS

22.6

6.7

1DB03

NOMESCO Finland

22.6

6.7

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

4.4

6.6

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.7

6.6

162

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

4.2

6.6

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.4

6.6

214

B73

ICPC

Leukaemia

12.3

6.6

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

12.3

6.6

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

8.7

6.5

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

3.3

6.5

KA1FN

NOMESCO Finland

Isotope renography

4.3

6.5

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

4.8

6.5

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

2.6

6.5

172

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

4.1

6.5

TGA30

NOMESCO Finland

Thoracocentesis

4.1

6.5

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

5.0

6.5

KBV00

NOMESCO Finland

Insertion of stent into ureter

5.0

6.5

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

4.0

6.5

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

6.5

245

1731

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.7

6.5

HWH99

NOMESCO Finland

Other reoperation in surgery of mammary gland

6.2

6.5

1BC07

NOMESCO Finland

70.0

6.4

JL1AT

NOMESCO Finland

Biopsy of pancreas with ultrasound guidance

14.3

6.4

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.1

6.4

309

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

4.1

6.4

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.9

6.4

423

K92.1

ICD-10 Finland

Melaena

1.9

6.4

481

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.0

6.3

373

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

5.2

6.3

RS140

NOMESCO Finland

9.3

6.3

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

3.6

6.3

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

4.6

6.3

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

18.1

6.3

9673/3-C77.9

ICD-O-3

Mantle cell lymphoma of lymph node, NOS

18.1

6.3

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

18.1

6.3

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

18.1

6.3

C56.73

ICD-10 Finland

Endomeroid epithelial carcinoma of the ovary

6.3

6.2

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

6.3

6.2

Z51.88

ICD-10 Finland

Other specified medical care

2.6

6.2

159

K83.1

ICD-10 Finland

Obstruction of bile duct

3.0

6.1

107

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

3.0

6.1

107

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

3.2

6.1

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.4

6.1

WX400

NOMESCO Finland

Inhalation anesthesy

1.9

6.1

460

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

3.5

6.1

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

4.0

6.1

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

12.5

6.1

GDG10

NOMESCO Finland

Bilateral transplantation of lung

12.5

6.1

C85.7

ICD-10 Finland

Other specified types of non-Hodgkin lymphoma

12.5

6.1

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

3.9

6.1

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

2.9

6.1

123

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.3

6.1

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

8.6

6.1

D76

ICPC

Malignant neoplasm pancreas

8.6

6.1

F20.5

ICD-10 Finland

Residual schizophrenia

4.4

6.0

L01XE11

ATC

[U] pazopanib; oral

10.0

6.0

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

10.0

6.0

176

Kela drug reimbursment

Regorafenib

10.0

6.0

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

10.0

6.0

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.5

6.0

180

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(4035726)

830

2102

5.31

317.82

1.7

1.4

—

(3023368) Bacteria identified in Blood by Culture

1725

5895

6.63

307.65

8.5

4.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

439

531

9.73

307.65

2.3

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

386

377

11.83

307.65

2.3

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

433

519

9.80

307.65

2.3

1.6

—

(3017181) Myelocytes/100 leukocytes in Blood

811

1933

5.63

307.65

5.5

4.1

1.5

0.9

6.55

565

536

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

334

289

13.10

307.65

2.0

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

373

445

9.61

295.50

8.2

5.0

iu/ml

453.5

706.5

0.35

(3004809) Band form neutrophils/100 leukocytes in Blood

332

351

10.69

287.65

3.9

3.4

2.1

1.3

2.57

290

274

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1091

3693

4.35

284.65

9.0

3.3

mmol/l

0.8

20.16

1066

3448

(3021440) Promyelocytes/100 leukocytes in Blood

733

1844

5.13

279.58

5.4

4.2

0.3

0.1

7.11

514

495

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

274

232

13.07

275.20

2.1

1.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1037

3543

4.19

263.91

2.7

1.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2105

11820

4.96

258.19

19.1

6.3

umol/l

9.9

11.2

5.33

2065

11232

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

218

138

17.14

257.77

2.7

1.9

—

(3045142) Bone marrow Pathology biopsy report

275

260

11.70

256.91

1.8

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

218

146

16.19

250.24

1.5

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

318

384

9.29

248.50

2.2

1.6

—

(3011412) CD3 cells [#/volume] in Blood

238

191

13.60

246.59

3.1

1.9

e9/l

1.0

1.1

0.44

198

110

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

169

26.89

244.34

2.5

1.8

—

(1175426) CD3 cells/100 lymphocytes in Blood

211

147

15.52

236.96

2.7

1.9

76.1

71.5

2.12

206

137

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

456

864

6.18

236.41

2.6

1.9

ug/l

1.8

0.05

439

775

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

209

144

15.68

236.12

2.7

1.8

11.5

14.7

1.08

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

633

1606

4.88

235.72

2.3

1.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2186

13093

5.03

233.61

34.6

9.1

e9/l

3.2

4.1

81.05

2107

11436

(21494815) CD4 cells/100 lymphocytes in Specimen

217

163

14.42

233.59

2.6

1.9

31.7

46.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

664

1765

4.70

233.09

5.3

3.9

1.0

0.6

5.56

390

388

(21494814) CD8 cells/100 lymphocytes in Specimen

173

22.25

232.22

2.4

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

272

304

9.87

225.12

1.9

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

798

2500

4.15

224.41

8.9

4.3

u/l

258.3

246.3

1.08

781

2366

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

175

101

18.49

216.16

4.5

3.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

778

2452

4.09

216.07

2.4

1.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

206

162

13.72

215.67

2.1

1.6

—

(3025159) Blasts/100 leukocytes in Blood

632

1729

4.50

212.22

5.7

4.3

0.1

0.5

0.75

428

422

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

297

399

8.27

212.02

2.0

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

277

346

8.83

209.96

3.6

2.5

u/ml

23338.1

2135.9

0.56

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

767

2458

4.00

207.09

2.3

1.7

—

(3018418) pH of Serum or Plasma

1392

6740

3.27

192.99

10.1

4.0

7.4

0.43

543

1265

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

248

300

9.03

192.57

2.0

1.4

—

(40768795) Lymph node Pathology biopsy report

216

223

10.47

188.95

1.5

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

627

1855

4.13

187.69

10.0

3.7

mmol/l

1.2

0.05

607

1620

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

260

346

8.23

186.61

2.0

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

164

116

15.01

182.14

2.1

1.6

—

(42870588) Differential panel, method unspecified - Blood

1488

7671

3.17

181.83

10.4

5.9

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

163

116

14.92

180.40

2.1

1.6

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1898

11322

3.45

179.14

13.6

6.8

mmol/l

1.2

0.41

1427

9593

(3019069) Monocytes/100 leukocytes in Blood

1817

10569

3.34

178.83

11.6

6.4

9.7

8.6

17.15

1768

9889

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

170

137

13.20

174.98

2.0

1.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

709

2412

3.66

171.88

5.9

4.1

ug/l

28.5

22.8

0.27

592

1950

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1773

10319

3.22

171.13

11.6

6.0

mmol/l

1.2

0.06

1709

9344

(3002030) Lymphocytes/100 leukocytes in Blood

1825

10833

3.25

169.48

11.4

6.2

27.5

28.0

0.86

1767

10083

(3006504) Eosinophils/100 leukocytes in Blood

1786

10514

3.19

167.40

11.2

6.1

2.2

2.8

20.57

1735

9797

(3022096) Basophils/100 leukocytes in Blood

1750

10222

3.14

165.55

11.1

6.1

0.6

0.7

1.93

1702

9533

(40760892) CBC W Ordered Manual Differential panel - Blood

1064

4874

2.99

154.33

9.7

4.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

182

197

9.85

153.42

1.4

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

175

184

10.12

150.67

1.8

1.6

—

(3018010) Neutrophils/100 leukocytes in Blood

1748

10697

2.90

142.49

10.5

6.0

54.9

57.2

7.02

1692

10002

(3006315) Basophils [#/volume] in Blood

1804

11254

2.93

141.21

10.9

5.9

e9/l

0.0

36.30

1672

9711

(3001604) Monocytes [#/volume] in Blood

1796

11205

2.91

140.04

10.9

5.9

e9/l

0.6

0.43

1665

9664

(3021879) Hepatitis B virus core Ab [Presence] in Serum

489

1487

3.81

137.68

1.5

1.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1629

9719

2.79

137.49

9.0

4.9

g/l

32.8

35.5

56.15

1566

9048

(3013115) Eosinophils [#/volume] in Blood

1832

11647

2.90

135.95

11.9

6.1

e9/l

0.1

0.2

60.29

1708

10199

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

43.96

135.94

2.1

2.4

mg/l

1.7

1.5

0.17

(3000850) Epithelial cells [#/volume] in Urine

992

4626

2.84

135.75

3.3

2.6

e6/l

6.4

5.9

0.43

921

4030

(3019198) Lymphocytes [#/volume] in Blood

1816

11502

2.88

135.56

11.1

5.9

e9/l

1.6

1.9

8.61

1693

10115

(3005719) IgG [Mass/volume] in Serum or Plasma

526

1698

3.62

135.31

4.8

2.7

g/l

9.1

10.6

6.65

504

1545

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

636

2336

3.27

133.03

6.4

3.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

649

2415

3.24

132.81

4.4

2.6

1.8

0.39

613

2138

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

182

241

8.04

130.48

2.2

1.5

—

(3026782) Osmolality of Urine

926

4297

2.79

126.25

3.3

2.7

mosm/kgh2o

510.0

540.5

4.24

861

3646

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2349

17573

4.23

124.64

23.5

7.7

u/l

88.0

78.1

12.17

2320

16536

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

170

222

8.12

123.24

2.3

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

1218

6610

2.57

119.35

4.1

3.2

e6/l

134.2

80.3

0.43

1070

5054

(3023520) Reticulocytes [#/volume] in Blood

521

1811

3.34

118.13

4.1

2.7

e9/l

68.1

70.6

0.77

446

1371

(3032080) INR in Blood by Coagulation assay

1489

8921

2.55

117.54

9.9

9.1

inr

1.1

1.2

7.74

675

2556

(3017143) Hepatitis C virus Ab [Presence] in Serum

608

2328

3.10

117.04

1.7

1.5

—

(40761536) Microorganisms panel - Urine sediment

527

1864

3.29

115.97

5.1

4.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

239

480

5.38

113.80

1.6

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1348

7803

2.50

113.25

8.9

3.4

mmol/l

2.3

2.4

4.01

1277

6805

(3028026) IgM [Mass/volume] in Serum or Plasma

428

1351

3.59

112.64

2.6

1.8

g/l

1.1

1.4

2.93

409

1227

(44790048)

172

259

7.04

109.80

2.0

1.5

—

(44790047)

172

259

7.04

109.80

2.0

1.5

—

(44790049)

172

259

7.04

109.80

2.0

1.5

—

(44806118)

172

259

7.04

109.80

2.0

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

269

639

4.58

104.75

1.8

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

684

2967

2.77

103.29

8.1

5.9

mmol/l

1.0

0.42

669

2746

(3042936) Bacteria identified in Isolate by Culture

716

3181

2.72

103.16

2.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

126

145

9.08

101.00

3.8

2.0

e6/l

395.5

708.2

3.57

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

144

197

7.68

100.11

2.5

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

144

197

7.68

100.11

2.5

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

144

197

7.68

100.11

2.5

1.5

—

(3030467) Casts [#/volume] in Urine by Automated count

1105

6098

2.40

99.74

3.9

3.1

e6/l

0.4

0.11

959

4583

(3031040) Bacteria [#/volume] in Urine by Automated count

2026

14635

2.69

98.88

5.8

4.5

e6/l

717.8

1774.2

0.81

194

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

14.36

97.48

1.3

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1619

10627

2.37

96.60

7.3

4.0

—

(3042631) Mycobacterium sp identified in Specimen

172

296

6.15

96.32

2.1

2.9

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

256

625

4.43

96.07

1.8

1.3

—

(3021589) Normoblasts [#/volume] in Blood

1546

9964

2.34

96.06

24.6

9.5

e9/l

0.0

1.31

1367

8148

(36304419) Bacteria [Presence] in Urine

1072

5944

2.36

94.49

3.7

3.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

251

613

4.42

94.11

1.3

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

640

2803

2.70

93.79

1.7

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

380

1247

3.39

93.21

1.8

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

150

238

6.62

90.97

4.5

4.0

—

(3012501) Base excess in Blood by calculation

217

485

4.79

90.84

3.8

4.5

mmol/l

2.4

2.6

0.54

163

330

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

200

418

5.10

90.65

1.5

1.4

—

(3013290) Carbon dioxide [Partial pressure] in Blood

217

486

4.78

90.60

3.8

4.5

kpa

4.9

5.0

2.92

212

480

(3013826) Glucose [Moles/volume] in Serum or Plasma

1850

13076

2.41

89.93

8.7

4.7

mmol/l

6.7

0.02

1797

12260

(3027315) Oxygen [Partial pressure] in Blood

217

490

4.74

89.69

3.8

4.5

kpa

8.6

0.11

212

483

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

224

520

4.62

89.47

1.6

—

(3018095) Leukocytes [#/volume] in Urine

1279

7786

2.25

88.68

4.7

3.7

e6/l

97.1

98.2

0.02

1098

5465

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

271

744

3.95

86.62

2.5

2.7

—

(3010421) pH of Blood

232

580

4.29

84.17

3.9

4.2

7.4

7.03

212

479

(40758558) Short blood count panel - Blood

1024

5792

2.26

83.72

25.9

6.7

—

(3044640) Blood type and Crossmatch panel - Blood

1194

7212

2.20

82.69

4.6

2.4

—

(3029937) Albumin [Presence] in Urine by Test strip

1012

5800

2.21

79.06

5.3

4.1

estimate

0.0

1.28

529

1945

(3026008) Bacteria identified in Urine by Culture

1117

6719

2.15

76.56

3.4

3.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

102

130

8.12

75.18

5.1

2.6

39.1

42.0

0.42

(3018677) aPTT in Platelet poor plasma by Coagulation assay

685

3396

2.38

75.07

3.2

2.1

29.6

29.7

0.06

674

3293

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1153

7071

2.13

74.62

3.5

2.6

u/l

51.9

57.9

4.62

1097

6511

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

173

377

4.84

74.44

1.5

1.4

u/ml

105.7

122.0

0.65

(40768793) Breast Pathology biopsy report

221

612

3.85

69.42

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

9.28

68.33

1.5

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

644

3288

2.27

64.64

1.8

1.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

341

1292

2.88

64.23

9.0

3.7

u/ml

63.8

60.8

0.09

330

1247

(1616796) Gas panel - Central venous blood

183

471

4.10

63.57

3.6

3.8

—

(40767503) Oxygen content in Capillary blood by calculation

179

456

4.14

63.04

2.7

2.6

15.0

16.2

2.79

238

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

478

2173

2.47

62.37

2.4

2.2

g/l

0.2

5.16

457

2044

(3025941) Bacteria identified in Stool by Culture

329

1247

2.87

61.83

1.5

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

137

296

4.83

59.44

1.2

1.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

334

1305

2.79

59.17

5.5

7.5

mmol/l

24.9

0.02

329

1298

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

133

6.97

58.22

3.7

1.9

e6/l

560.5

493.3

0.34

113

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

160

405

4.14

56.77

1.3

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

417

1866

2.47

55.87

3.6

2.8

g/l

64.4

66.6

5.89

399

1699

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1114

7320

1.91

54.24

6.8

3.2

u/l

38.4

33.8

1.56

1069

6955

(3004588) Protein electrophoresis panel - Serum or Plasma

364

1560

2.55

53.33

2.3

2.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

151

384

4.11

53.21

1.3

1.2

u/ml

264.5

274.4

0.14

105

238

(1617658) Protocol used for examination of sentinel lymph nodes

108

210

5.32

52.89

1.0

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

130

298

4.54

52.43

5.4

7.4

mg/l

11.9

12.0

0.13

122

276

(3020779) Urea [Moles/volume] in Serum or Plasma

422

1952

2.38

52.31

9.5

7.9

mmol/l

8.7

9.7

2.28

408

1875

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

7.68

51.01

1.3

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

193

599

3.40

50.81

1.3

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

438

2087

2.32

50.60

2.9

2.2

nmol/l

368.5

367.1

0.04

421

1911

(3007853) Bacteria identified in Skin by Aerobe culture

507

2584

2.19

49.69

1.8

1.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

909

5734

1.90

48.95

4.9

3.4

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

583

3163

2.08

48.46

2.3

2.5

g/l

2.2

2.3

7.08

557

2935

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1192

8215

1.83

48.15

5.4

3.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1210

8403

1.82

47.43

4.2

3.5

ng/l

24.1

104.2

0.83

986

5724

(3022948) Iron [Moles/volume] in Serum or Plasma

610

3429

2.02

45.67

2.4

2.5

umol/l

13.1

13.2

0.18

581

3171

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

193

643

3.16

45.18

2.9

2.5

g/l

3.7

3.6

0.52

187

607

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

126

6.27

45.17

4.1

2.0

e9/l

0.2

0.31

112

(3008536) Aspergillus sp Ab [Presence] in Serum

11.09

45.14

3.3

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

120

6.40

44.98

3.1

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

120

6.40

44.98

3.1

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

120

6.40

44.98

3.1

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

120

6.40

44.98

3.2

1.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

545

2957

2.06

44.92

2.3

2.6

24.9

23.0

1.81

500

2526

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

113

262

4.46

44.90

3.0

1.8

ug/l

23.2

23.4

0.02

113

256

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

7.06

44.13

3.3

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

7.06

44.13

3.3

1.6

—

(40765096) Chromosome analysis panel by Banding

7.95

43.90

1.2

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

6.99

43.72

3.3

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

100

216

4.77

43.35

1.3

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2010

22700

0.51

42.53

4.5

5.0

mmol/l

2.7

2.8

0.96

1815

20872

(3032352) Blasts [#/volume] in Cerebral spinal fluid

15.86

41.76

2.8

2.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

220

4.64

41.46

3.3

3.4

53.6

56.8

0.47

143

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

101

229

4.55

41.26

2.6

2.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1889

15336

1.83

40.64

5.9

4.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

9.38

40.12

1.6

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

7.25

39.88

1.4

2.3

u/ml

657.1

35792.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1950

22142

0.53

39.26

4.2

4.5

mmol/l

1.5

3.73

1767

20348

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

473

2556

2.04

38.89

5.5

2.7

umol/l

13.2

8.2

2.39

428

2224

(3021601) Nitrite [Presence] in Urine by Test strip

1432

10839

1.71

38.42

6.3

5.0

estimate

0.0

0.50

566

2010

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

147

460

3.33

38.09

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

147

460

3.33

38.09

1.4

1.3

—

(40768804) Tissue Pathology biopsy report

1284

9465

1.70

37.78

2.5

2.1

—

(3009261) Glucose [Presence] in Urine by Test strip

1441

10955

1.70

37.77

5.2

3.7

estimate

0.0

1.08

562

1944

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1976

22306

0.54

37.72

4.2

4.5

mmol/l

4.7

0.74

1813

20633

(3035350) Ketones [Presence] in Urine by Test strip

1423

10796

1.70

37.46

5.2

3.7

estimate

0.0

0.00

564

1966

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

194

730

2.79

36.43

3.0

3.2

u/ml

0.4

0.00

120

421

(3033658) Prothrombin time (PT) actual/Normal

864

5785

1.74

35.66

6.7

3.8

89.9

91.4

1.02

847

5633

(3028626) Oxygen [Partial pressure] in Capillary blood

146

477

3.18

35.24

3.0

2.9

kpa

8.1

0.16

138

437

(3014576) Chloride [Moles/volume] in Serum or Plasma

492

2787

1.94

35.02

8.8

7.1

mmol/l

103.9

104.3

0.98

474

2734

(3021447) Carbon dioxide [Partial pressure] in Venous blood

382

1982

2.09

34.80

4.9

3.7

kpa

5.6

5.8

4.08

371

1926

(3003694) ABO and Rh group [Type] in Blood

883

5982

1.72

34.74

1.7

1.4

—

(3002256) Pathology report gross observation

521

3030

1.90

34.17

1.4

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

830

5554

1.72

34.00

4.2

2.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

669

4210

1.79

33.99

6.0

3.0

mmol/l

2.5

3.23

623

3710

(3002032) Base excess in Venous blood by calculation

378

1975

2.07

33.73

5.0

3.7

mmol/l

2.2

2.0

0.73

305

1620

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

148

502

3.06

33.51

5.1

3.5

u/ml

232.7

863.3

0.65

138

467

(3018405) Lactate [Moles/volume] in Arterial blood

195

778

2.63

32.61

4.4

3.9

mmol/l

1.6

1.4

0.92

189

766

(3014111) Lactate [Moles/volume] in Serum or Plasma

369

1936

2.05

32.48

6.6

7.2

mmol/l

1.4

1.3

0.99

360

1872

(21494434) Karyotype in Bone marrow

210

4.20

31.97

1.4

1.2

—

(3023419) Bacteria identified in Sputum by Culture

105

301

3.59

31.16

2.2

2.7

—

(40768806) Pleura Pathology biopsy report

225

4.01

30.76

1.4

1.5

—

(3028433) Virus identified in Specimen by Culture

6.52

30.73

1.3

1.2

—

(3016502) Oxygen saturation in Arterial blood

405

2242

1.95

30.51

8.7

8.3

95.5

95.7

0.19

393

2169

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

197

816

2.53

30.47

4.3

3.5

u/ml

3732.3

1989.4

0.20

174

689

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

7.99

30.27

1.5

1.0

—

(3021901) Oxygen saturation in Capillary blood

122

395

3.19

29.88

2.8

2.9

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

274

1327

2.19

29.61

4.3

3.6

mmol/l

2.3

1.8

1.45

210

1014

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

223

992

2.36

29.50

1.9

1.8

g/l

1.6

0.51

194

864

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

10.11

29.18

1.4

1.7

—

(3019060) Gas panel - Arterial blood

289

1446

2.12

28.71

6.9

5.3

—

(3009343) pH of Capillary blood

280

1386

2.14

28.60

4.4

3.7

7.4

2.98

174

(3008152) Bicarbonate [Moles/volume] in Arterial blood

273

1346

2.15

28.15

9.7

7.6

mmol/l

24.8

24.5

0.46

262

1256

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

208

921

2.37

27.78

3.3

1.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

140

515

2.82

27.38

2.1

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

217

3.87

27.34

1.8

1.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

279

1403

2.11

27.31

4.4

3.7

kpa

5.0

5.2

2.55

264

1303

(3000494) Fungus identified in Specimen by Culture

458

2727

1.82

27.30

1.9

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

147

557

2.74

27.18

3.0

3.2

mmol/l

24.6

25.0

0.50

135

482

(3000991) Gas panel - Venous blood

339

1839

1.97

26.90

8.3

8.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

836

5891

1.62

26.69

5.7

2.6

umol/l

2001.4

4538.2

1.85

773

5103

(3003434) Protein [Mass/volume] in Pleural fluid

279

3.46

26.48

1.4

1.5

g/l

36.9

33.0

2.64

248

(3003396) Base excess in Arterial blood by calculation

429

2528

1.83

26.38

8.5

7.8

mmol/l

1.9

1.1

4.40

339

1980

(40758292) HTLV I+II Ab panel - Serum

9.49

26.20

1.4

—

(3027801) Oxygen [Partial pressure] in Arterial blood

430

2542

1.83

26.15

8.5

7.8

kpa

12.5

0.07

415

2429

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

430

2542

1.83

26.15

8.5

7.8

kpa

5.0

5.1

1.69

412

2430

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

287

3.36

25.34

1.4

1.5

nmol/l

0.3

0.18

212

(3020891) Body temperature

197

889

2.31

25.16

5.5

4.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

641

4283

1.66

25.06

2.1

1.5

g/l

2.1

2.4

3.69

495

2571

(3001964) Herpes simplex virus Ag [Presence] in Specimen

6.39

24.82

1.9

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

165

696

2.46

24.51

2.8

2.1

87.1

90.9

1.12

150

648

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

212

3.71

24.28

1.2

1.3

—

(3037756) Immunofixation for Serum or Plasma

130

490

2.74

24.28

1.6

1.7

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

132

506

2.69

23.86

2.1

1.4

e6/l

12.4

31.4

0.77

118

384

(3012441) Differential panel - Pleural fluid

220

3.62

23.75

1.3

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

105

357

3.02

23.69

1.2

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

6.23

23.65

3.6

2.0

9.9

9.3

0.08

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

9.42

23.54

2.0

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

225

1105

2.13

23.33

3.7

2.8

e6/l

0.2

0.3

0.98

219

1075

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

6.14

23.29

4.4

1.9

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

131

507

2.67

23.24

2.2

1.5

e6/l

266.9

1194.9

0.96

122

409

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1856

20788

0.63

23.15

5.3

5.8

mmol/mol

39.9

39.7

0.32

1690

19205

(3002173) Hemoglobin [Mass/volume] in Arterial blood

360

2089

1.84

23.07

9.4

8.8

g/l

111.9

121.4

14.41

349

2017

(3024471) HLA-A [Type]

6.05

22.95

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1926

21384

0.63

22.90

3.9

4.0

mmol/l

1.4

1.3

4.94

1740

19515

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

5.98

22.15

1.6

1.2

17.9

11.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

293

1617

1.91

21.91

4.4

3.0

kpa

4.7

4.6

0.11

285

1566

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

141

584

2.49

21.78

1.9

1.3

mg/l

741.8

510.5

0.63

134

550

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

107

386

2.85

21.72

1.2

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

701

4930

1.58

21.71

2.2

1.8

mg/l

2.1

1.2

4.45

551

3798

(3000060) B lymphocytes [#/volume] in Blood

7.46

21.64

3.5

1.8

e6/l

92.9

140.0

0.43

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

138

580

2.46

20.66

3.8

3.2

mg/l

1.5

1.6

0.61

129

535

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

195

951

2.13

20.56

4.4

3.8

50.7

49.6

0.22

195

937

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

179

846

2.20

20.42

2.4

1.8

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

102

4.67

20.33

2.0

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

102

4.67

20.33

2.0

1.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

851

6323

1.51

20.25

3.3

3.0

ng/l

1474.2

1197.6

0.85

765

5402

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

766

5571

1.53

20.14

2.2

mg/l

3.3

3.0

2.75

692

4734

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

129

4.17

19.85

1.9

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

149

663

2.32

19.64

4.9

4.1

mmol/l

3.8

3.9

0.28

134

627

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

127

4.16

19.40

1.9

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

191

3.52

19.38

1.2

1.1

—

(3000012) Reticulocyte production index

115

4.32

19.25

1.3

1.6

—

(3024932) HLA-DR beta [Type]

5.60

19.15

1.4

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

296

2.97

19.03

2.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

291

2.99

18.99

2.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

291

2.99

18.99

2.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

298

2.95

18.81

2.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

293

2.96

18.76

2.5

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

131

562

2.40

18.76

1.3

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

121

501

2.48

18.72

4.6

2.0

u/l

93.4

3323.5

4.13

196

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

301

2.92

18.48

2.5

1.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

5.13

18.36

1.4

1.5

64.1

58.5

0.37

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

111

4.29

18.32

1.7

1.4

62.4

72.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2396

22271

1.88

18.29

41.8

14.2

mg/l

28.1

23.4

10.95

2247

17580

(3044889) 12 lead EKG panel

1828

15961

1.48

18.10

4.9

3.8

—

(3044290) Cell count panel - Cerebral spinal fluid

115

474

2.49

17.97

2.1

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

240

1330

1.89

17.62

2.3

1.6

—

(3015736) pH of Urine

1057

8366

1.44

17.59

4.6

3.4

—

5.9

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

6.57

17.47

1.3

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

242

3.03

16.64

1.2

u/l

80.1

56.2

1.30

171

(3027273) Bicarbonate [Moles/volume] in Venous blood

195

1028

1.97

16.61

4.5

3.2

mmol/l

25.2

25.4

0.38

190

1000

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

194

1021

1.97

16.60

5.1

4.0

mmol/l

24.2

0.10

174

923

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

186

3.33

16.56

1.3

u/l

545.8

359.5

0.97

180

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

143

3.69

16.50

1.4

u/l

12.2

13.4

0.29

135

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

223

3.10

16.40

4.1

2.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

100

4.25

16.23

39.0

26.7

ug/l

134.5

117.8

0.67

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.30

16.08

1.2

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

146

3.61

16.02

1.2

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1170

9542

1.41

15.96

2.6

2.3

nmol/l

78.0

78.3

0.15

1103

8559

(40760888) Immunoglobulin light chains.free panel - Serum

121

540

2.30

15.87

2.9

4.0

—

(40757373) Influenza virus identified in Isolate

5.89

15.72

2.0

1.6

—

(4281824)

278

2.82

15.68

1.3

1.1

—

(40768441) Liver Pathology biopsy report

178

3.31

15.60

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.41

15.42

1.2

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

111

484

2.35

15.36

2.5

2.3

g/l

118.7

129.9

4.89

351

(3002385) Erythrocyte distribution width [Ratio]

2039

18403

1.49

15.33

46.3

17.4

14.6

13.7

75.93

2024

17999

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

146

3.54

15.28

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

28.77

15.18

2.3

1.7

—

(3008295) Osmolality of Serum or Plasma

239

2.94

15.16

1.2

1.3

mosm/kgh2o

277.6

278.7

0.17

183

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2029

21920

0.67

15.12

4.7

mmol/l

5.9

0.15

1860

19947

(3003338) MCHC [Mass/volume]

1661

18590

0.71

15.04

50.5

18.4

g/l

331.1

332.1

4.88

1651

18476

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

129

3.69

14.98

1.3

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

120

3.80

14.95

1.2

1.1

u/l

102.5

80.0

0.68

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

10.06

14.92

1.2

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

500

3511

1.52

14.85

3.8

2.9

e6/l

3.0

2.6

0.41

310

1896

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

121

3.77

14.77

1.2

1.1

u/l

38.9

20.3

0.77

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

645

4793

1.46

14.42

1.7

pmol/l

17509508.1

31915863.4

0.34

554

3973

(3003181) Sodium [Moles/volume] in Urine

393

2.44

14.30

1.3

mmol/l

66.6

62.7

0.40

322

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

144

720

2.06

14.22

2.9

3.8

mg/l

27.4

57.5

1.90

100

590

(3009466) Valproate [Moles/volume] in Serum or Plasma

331

2.56

13.95

6.8

5.3

umol/l

394.2

359.6

1.31

287

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

140

698

2.06

13.94

2.9

3.8

ratio

2.2

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

143

719

2.05

13.92

2.9

3.8

mg/l

47.2

62.7

0.68

100

589

(3051651) Icteric interference index of Serum or Plasma

146

3.40

13.84

4.7

3.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

263

2.75

13.81

1.5

1.4

e6/l

2525.1

1969.3

0.33

182

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

8.23

13.63

1.1

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

360

2.47

13.55

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.81

13.54

1.3

1.1

—

(3035880) pH of Pleural fluid

111

3.74

13.35

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

5.14

13.16

1.2

ug/l

91.2

103.2

0.06

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

100

448

2.28

13.04

1.4

1.7

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

178

996

1.84

12.66

3.6

2.5

0.7

0.91

171

957

(3035637) Corticotropin [Mass/volume] in Plasma

271

2.63

12.53

1.7

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

231

2.77

12.52

1.5

1.4

e6/l

22788.2

111079.0

1.53

127

(3023183) Ammonium ion [Moles/volume] in Plasma

104

484

2.20

12.39

2.4

3.0

umol/l

34.8

0.00

415

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

180

1020

1.82

12.29

3.6

2.6

1.2

0.21

180

1011

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

130

664

2.01

12.14

1.5

1.1

—

(3019977) pH of Arterial blood

110

3.58

12.00

2.4

3.1

7.4

0.52

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

283

1828

1.61

11.98

5.4

2.6

ml/min/173m2

56.7

65.7

3.56

116

729

(3014765) Yersinia sp identified in Stool by Organism specific culture

130

672

1.98

11.75

1.5

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

541

4026

1.43

11.69

1.9

1.7

nmol/l

1416.1

1167.3

7.72

441

3010

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

4.94

11.68

1.4

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

125

639

2.00

11.66

3.2

2.4

205.4

190.0

1.06

119

608

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

30.16

11.64

1.8

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

108

3.56

11.57

1.9

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

108

3.56

11.57

1.9

1.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

130

678

1.97

11.46

1.5

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

130

679

1.96

11.41

4.2

3.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

435

2.20

11.38

2.0

3.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

234

2.65

11.15

16.5

6.3

mmol/l

8.1

7.3

0.47

198

(40761535) Cells panel - Urine sediment

283

1862

1.58

11.07

4.5

3.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

256

2.54

10.77

1.2

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

5.59

10.69

1.8

1.4

—

(3046861) Legionella sp Ag [Presence] in Urine

21.54

10.67

1.1

1.0

—

(3013862) HLA-DP [Type]

21.54

10.67

1.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

151

3.01

10.54

1.5

1.6

u/l

7.0

6.9

0.00

(3044242) Glucose [Moles/volume] in Arterial blood

115

3.34

10.54

2.6

2.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

304

2.37

10.34

1.5

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

157

902

1.79

10.27

1.6

1.4

iu/l

34.1

31.7

0.36

134

774

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

5.84

10.06

1.2

—

(3013512) EKG study

825

6729

1.33

9.86

4.2

3.8

—

(3009871) Measles virus Ab [Titer] in Serum

3.92

9.85

1.8

1.7

—

(46236302) HLA-C [Type] by High resolution typing

20.10

9.80

1.0

—

(40760410) HLA-B [Type] by High resolution

20.10

9.80

1.0

—

(40760409) HLA-A [Type] by High resolution

20.10

9.80

1.0

—

(40763590) HLA-DQ beta [Type]

20.10

9.80

1.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

151

872

1.78

9.72

9.0

6.1

1.7

1.6

0.32

142

814

(3014148) Varicella zoster virus Ab [Titer] in Serum

227

2.54

9.71

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

204

2.63

9.67

1.3

1.4

mmol/l

5.6

6.5

1.50

189

(3009214) Lutropin [Units/volume] in Serum or Plasma

479

2.04

9.62

1.7

1.3

u/l

13.7

11.4

0.73

390

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

140

2.96

9.35

2.5

1.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

497

3777

1.39

9.31

3.7

2.7

e6/l

1.3

1.1

0.54

312

2152

(3036489) Thrombin time

146

848

1.76

9.22

2.9

2.0

21.7

21.5

0.09

132

745

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

112

600

1.91

9.18

1.7

2.0

mg/l

11.6

11.8

0.04

107

552

(21494755) Public health laboratory ask at order entry panel

1782

0.52

9.14

1.2

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

358

4852

0.70

9.06

4.6

4.3

21.4

21.3

0.01

196

2395

(3019550) Sodium [Moles/volume] in Serum or Plasma

2416

23108

1.58

8.99

37.9

16.3

mmol/l

139.1

139.7

28.62

2381

22542

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

102

1848

0.53

8.97

1.6

1.7

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

24.09

8.90

1.1

1.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

147

867

1.74

8.81

9.1

6.2

0.9

0.06

138

810

(3016038) Potassium [Moles/volume] in Urine

137

2.87

8.49

1.1

1.2

mmol/l

35.5

33.8

0.20

122

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

472

3610

1.37

8.44

1.5

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2417

23179

1.55

8.20

38.3

16.4

mmol/l

4.0

0.77

2381

22579

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

246

3515

0.67

8.19

2.6

3.1

ug/l

0.9

0.7

0.92

170

2369

(3017569) Oxygen content in Arterial blood

113

3.04

8.16

2.7

2.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

9.12

8.09

3.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.25

8.07

3.3

4.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

366

2.08

8.03

1.3

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

159

984

1.66

8.00

1.7

1.9

u/l

40.9

38.5

0.61

146

869

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1093

9448

1.27

7.94

3.1

2.8

ug/l

383.5

127.7

16.02

1031

8717

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

120

692

1.77

7.81

1.5

1.6

iu/ml

0.0

10.1

0.50

120

(3022313) Gas panel - Capillary blood

162

1014

1.64

7.80

5.4

3.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

499

6282

0.75

7.79

1.8

1.6

mmol/l

1.5

1.4

1.07

402

5278

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

4.19

7.73

1.5

1.3

—

(3047181) Lactate [Moles/volume] in Blood

116

666

1.78

7.67

10.4

7.5

mmol/l

1.3

0.22

101

585

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

4.11

7.53

1.3

1.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1823

16806

1.28

7.48

6.3

4.2

mm/h

19.0

12.3

34.71

1721

15545

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1244

0.49

7.29

1.5

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

369

0.21

7.22

2.0

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

109

626

1.77

7.22

1.3

1.2

titre

119.5

88.0

0.46

(3033799) Differential panel - Peritoneal fluid

3.45

7.11

1.2

2.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

163

2.54

7.09

2.2

1.5

ug/l

1.3

4.6

1.29

134

(3016018) Differential panel - Cerebral spinal fluid

250

2.23

7.08

2.3

1.4

—

(3045788) Cell count panel - Pleural fluid

206

2.35

7.06

1.4

1.5

—

(3022145) Colonoscopy Study observation

349

2616

1.39

7.00

1.4

1.3

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

3.71

6.91

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

3.71

6.91

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

3.71

6.91

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

3.71

6.91

1.0

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

292

2135

1.41

6.77

3.4

2.3

u/l

29.9

60.0

0.76

263

1847

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

105

2.88

6.63

1.0

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

239

2.20

6.55

4.6

3.5

—

(3020393) Adenovirus Ag [Presence] in Stool

6.13

6.43

1.3

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

130

2.64

6.39

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

18.05

6.26

1.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

125

779

1.63

6.18

3.3

2.6

g/l

1.2

1.1

0.10

111

682

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

137

874

1.60

6.17

5.9

3.9

mmol/l

25.3

24.9

0.77

132

816

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

362

1.93

6.13

1.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

348

1.95

6.13

1.4

1.7

g/l

0.6

0.8

0.53

262

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.97

6.11

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

629

5227

1.27

6.01

1.7

1.5

nmol/l

19.5

20.9

1.25

575

4422

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

807

6906

1.24

5.96

2.9

2.1

u/l

192.1

211.1

0.18

765

6486

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

133

850

1.59

5.95

3.0

2.6

g/l

3.4

3.1

2.03

107

665

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

3.16

5.74

1.0

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

2.93

5.73

1.2

1.6

umol/l

2.2

2.1

0.32

(3027135) IgG subclass 1 [Mass/volume] in Serum

214

2.17

5.67

1.4

1.5

g/l

6.3

6.8

0.34

146

(3024139) IgG subclass 3 [Mass/volume] in Serum

214

2.17

5.67

1.4

1.5

g/l

0.4

0.10

146

(3028192) IgG subclass 2 [Mass/volume] in Serum

214

2.17

5.67

1.4

1.5

g/l

2.5

2.9

0.52

147

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

215

2950

0.70

5.66

4.0

4.6

31.4

32.6

0.89

152

1981

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

3.04

5.64

1.1

2.2

e6/l

27203.8

27584.7

0.00

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

5.90

5.62

4.1

9.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.41

5.58

1.8

3.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.41

5.58

1.8

3.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

111

690

1.64

5.58

3.2

2.5

g/l

0.0

0.15

106

635

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

277

2.01

5.52

1.4

u/l

41.3

29.7

1.56

228

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

105

2.68

5.50

1.9

6.1

—

58.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

107

663

1.64

5.45

2.3

1.6

g/l

0.2

0.36

630

(4062490)

218

2.13

5.42

1.4

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1585

14614

1.21

5.41

4.5

3.2

u/l

81.8

48.7

11.28

1494

13574

(3043410) Blood group antigens tested for on Red Blood Cells

3.03

5.37

1.9

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

4.13

5.36

1.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

137

906

1.54

5.32

2.9

2.5

g/l

3.7

3.8

0.33

106

651

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

137

906

1.54

5.32

2.9

2.5

g/l

7.6

7.4

0.66

109

682

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

137

906

1.54

5.32

2.9

2.5

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

11.28

5.29

1.1

1.0

—

(3019150) Specific gravity of Urine by Refractometry

565

4702

1.26

5.25

5.4

4.1

kg/l

1.0

0.29

668

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

126

2.48

5.20

1.2

1.1

ratio

1.1

1.0

0.51

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

369

1.84

5.19

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

3.14

5.19

8.0

1.7

—

(1002224) Polysomnography panel

882

0.50

5.17

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

139

2.39

5.14

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

127

2.46

5.12

1.5

1.7

u/field

2.4

3.6

0.36

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

120

778

1.57

5.10

2.7

2.3

ug/l

307.5

526.4

0.99

110

735

(3037121) Protein [Mass/volume] in Urine

121

788

1.56

5.04

6.3

3.1

g/l

0.4

0.3

0.16

314

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.77

5.04

1.2

2.4

e6/l

759.4

816.6

0.08

(3011325) HIV 1+2 Ab [Presence] in Serum

10.03

5.02

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

135

2.39

4.98

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

135

2.39

4.98

1.1

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

198

1430

1.42

4.95

1.5

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

108

689

1.59

4.92

2.3

1.6

g/l

1.2

0.20

101

655

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

4.30

4.82

2.3

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

4.30

4.82

2.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

4.30

4.82

2.3

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.96

4.71

1.0

1.5

g/l

13.8

13.9

0.02

(3017732) Neutrophils [#/volume] in Blood

213

1576

1.38

4.64

4.1

3.2

e9/l

3.8

4.0

0.56

176

1231

(3035933) Granulocytes/100 leukocytes in Blood

3.12

4.63

4.9

2.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.15

4.62

3.5

4.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

156

1093

1.45

4.62

1.5

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

134

2.33

4.59

1.2

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

613

7130

0.82

4.53

4.1

4.0

mg/mmol

10.4

8.9

0.40

361

4403

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

165

1173

1.43

4.52

12.3

11.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

10.03

4.52

2.6

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

208

2.04

4.47

1.2

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

124

839

1.50

4.38

3.0

2.6

g/l

10.0

10.3

0.25

110

713

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.24

4.35

1.2

1.3

—

(3010937) Rubella virus Ab [Presence] in Serum

7.52

4.35

1.0

—

(3042733) HLA Ab [Presence] in Serum

2.89

4.33

5.7

4.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2214

21286

1.26

4.32

36.1

13.2

ml/min/173m2

81.8

80.4

2.46

2054

17580

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.60

4.30

1.0

1.1

miu/ml

1193.8

1620.2

0.95

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

11.69

4.27

2.9

1.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

107

711

1.53

4.13

3.2

2.4

g/l

34.9

37.9

5.62

614

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

8.02

4.06

1.5

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

175

2.07

4.06

1.2

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

3.35

4.04

1.2

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

10.02

4.01

1.6

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.68

3.99

1.3

1.2

—

(3039000) Anion gap in Blood

472

1.63

3.93

14.4

8.8

mmol/l

10.7

11.4

0.99

422

(3018572) Chloride [Moles/volume] in Blood

473

1.62

3.90

14.4

8.8

mmol/l

105.9

105.1

0.62

423

(3044007) Cell count panel - Peritoneal fluid

2.78

3.85

1.2

2.2

—

(4146454)

274

0.33

3.81

1.4

2.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1988

20711

0.83

3.76

5.3

4.9

mu/l

3.4

2.1

0.43

1843

18949

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

646

1.52

3.74

3.4

2.5

g/l

0.0

0.00

593

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

334

0.33

3.74

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

2.46

3.71

1.2

1.1

ng/l

3060.0

410.8

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

253

1.83

3.67

1.3

1.7

—

1382.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

239

1.86

3.65

1.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

3.44

3.62

1.2

1.6

—

(3004451) EKG impression Narrative

117

2.23

3.57

1.3

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

200

1.91

3.48

3.7

2.3

—

(40768797) Stomach Pathology biopsy report

395

3301

1.23

3.47

1.3

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

341

2805

1.25

3.47

14.1

23.8

inr

1.4

1.3

0.63

396

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

524

6046

0.83

3.42

5.4

5.0

ug/l

4.7

2.6

2.05

456

5400

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

160

1193

1.36

3.39

10.0

9.8

mmol/l

24.8

24.4

0.98

152

1123

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

316

0.35

3.38

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

476

1.57

3.36

3.5

4.0

mg/l

32.0

24.9

0.86

283

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

315

0.35

3.36

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

830

0.59

3.35

1.9

1.7

mg/l

5.5

3.9

0.39

592

(3012516) Albumin [Mass/volume] in Urine

595

6778

0.84

3.35

3.2

3.3

mg/l

813.5

353.9

0.92

357

4173

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

314

0.35

3.34

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

314

0.35

3.34

1.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

3.45

3.33

1.1

72.8

44.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

176

1.94

3.29

1.2

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

187

1436

1.33

3.27

3.6

3.4

pmol/l

4.5

0.05

166

1271

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.39

3.22

1.2

1.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.17

3.21

1.1

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.59

3.21

1.3

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

113

1566

0.71

3.21

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

325

3901

0.81

3.17

1.3

1.2

u/ml

22.3

11.7

1.12

124

1515

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

117

2.15

3.16

1.7

1.8

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

234

1862

1.28

3.15

2.2

2.4

ug/l

7.3

7.1

0.06

204

1660

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.96

3.13

2.2

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.90

3.02

2.2

1.1

—

(40768446) Kidney Pathology biopsy report

2.36

2.98

1.5

1.7

—

(3048879) Bone marrow aspiration report

2.55

2.95

2.3

1.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

5.40

2.87

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

193

2428

0.78

2.85

1.6

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

620

1.45

2.83

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

245

1.73

2.83

1.8

2.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

549

1.47

2.76

1.2

1.3

miu/ml

139.1

211.3

1.09

248

(3033705) Calcium.ionized [Moles/volume] in Venous blood

256

1.69

2.71

3.9

2.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

146

1.93

2.70

1.3

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

571

0.57

2.66

1.5

1.6

—

(3037522) Nuclear Ab [Titer] in Serum

365

3110

1.20

2.65

1.5

1.3

titre

708.6

527.7

0.80

666

(3009508) Creatinine [Moles/volume] in Urine

641

7141

0.86

2.63

3.4

3.2

mmol/l

6.7

7.3

3.23

531

6008

(3032057) Clostridioides difficile [Presence] in Stool

2.66

2.62

2.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

148

1.90

2.60

1.3

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

100

725

1.39

2.58

2.3

1.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

261

0.38

2.57

1.4

—

(40761511) CBC panel - Blood by Automated count

2368

23161

1.23

2.57

33.4

13.4

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.01

2.56

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

259

0.38

2.53

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

315

0.44

2.53

1.4

1.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.04

2.52

1.7

1.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

4.38

2.47

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.82

2.46

1.4

1.1

—

(4027681)

123

1.96

2.45

1.4

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

269

0.41

2.45

1.4

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

486

4276

1.17

2.43

3.6

ng/l

360.3

590.7

0.38

383

3276

(3019225) pH of Specimen

281

2356

1.22

2.42

7.8

4.2

—

(3030313) Adrenal Ab [Titer] in Serum

5.01

2.40

1.2

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.22

2.37

1.1

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

1946

20115

0.87

2.36

33.8

15.3

37.1

39.6

24.27

1222

14229

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

161

1.81

2.35

1.1

mg/l

631.7

266.5

0.66

139

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.32

2.31

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

615

1.39

2.26

2.0

1.6

mu/l

426.2

312.0

1.06

556

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.28

2.24

1.1

85.7

89.1

—

(3045414) Leukocytes [Presence] in Urine

135

1051

1.30

2.23

2.4

1.9

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.56

2.21

1.0

—

(4212803)

3.69

2.15

1.1

—

(3014891) Appearance of Pleural fluid

3.01

2.14

1.4

1.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.71

2.10

3.3

2.4

umol/l

16.7

18.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1109

0.73

2.10

1.6

1.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

216

1792

1.22

2.10

4.0

3.8

ng/l

97.1

86.0

0.74

193

1541

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

175

1.72

2.09

1.5

umol/l

13.3

12.3

0.30

166

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

168

1.73

2.07

1.1

mg/l

167.7

38.4

0.70

140

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

145

1811

0.79

2.07

1.6

1.9

—

(3047189) Immunofixation for 24 hour Urine

117

1.89

2.06

1.7

1.6

—

(3000963) Hemoglobin [Mass/volume] in Blood

2437

24705

0.81

2.04

58.8

21.2

g/l

122.7

134.9

238.02

2417

24351

(3010813) Leukocytes [#/volume] in Blood

2437

24703

0.81

2.02

58.6

21.1

e9/l

5.9

6.7

33.12

2401

24012

(1761868) Lipid panel - Serum or Plasma

713

7765

0.89

2.00

2.8

2.9

—

(3026361) Erythrocytes [#/volume] in Blood

2437

24698

0.81

1.96

58.5

21.0

e12/l

4.1

4.5

206.06

2402

24002

(3035941) MCH [Entitic mass]

2437

24697

0.81

1.95

58.2

21.0

30.5

30.3

4.13

2417

24346

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.19

1.94

1.1

1.3

78.3

90.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

186

0.43

1.93

1.4

1.5

—

(4010399)

134

1673

0.79

1.93

1.5

1.4

—

(3024731) MCV [Entitic volume]

2437

24694

0.81

1.92

58.3

21.0

92.1

91.1

18.04

2417

24345

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

358

4071

0.86

1.92

1.3

iu/ml

53.5

35.7

0.70

114

1297

(3000570) Elastase.pancreatic [Mass/mass] in Stool

679

1.34

1.89

1.4

ug/g

261.2

281.9

0.48

399

(3007461) Platelets [#/volume] in Blood

2437

24688

0.82

1.86

58.6

21.1

e9/l

225.6

253.0

56.55

2405

24068

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.40

1.85

1.5

1.2

—

(36660697) Celiac disease serology panel - Serum

139

1718

0.80

1.84

1.1

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

571

1.36

1.82

1.6

1.9

iu/l

4.0

5.2

0.57

200

(3016750) Collection duration of Urine

145

1.73

1.81

2.2

2.1

min

516.1

489.2

0.68

107

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.58

1.80

1.9

1.2

ng/l

169.4

95.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

138

0.36

1.74

1.2

1.4

—

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.51

1.74

1.2

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

132

1.75

1.73

1.2

1.1

—

(3022621) pH of Urine by Test strip

175

1454

1.22

1.72

3.2

3.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

3.85

1.71

1.0

1.5

nmol/l

69.1

12.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

269

0.52

1.71

1.1

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

285

1.48

1.64

2.1

1.6

59.9

61.0

0.07

175

(3008037) Lactate [Moles/volume] in Venous blood

470

1.37

1.64

4.5

3.1

mmol/l

1.6

1.5

0.05

453

(3008401) Mugwort IgE Ab [Units/volume] in Serum

290

0.55

1.63

1.1

u/ml

1.2

1.8

—

121

(3003888) Timothy IgE Ab [Units/volume] in Serum

302

0.56

1.61

1.1

u/ml

5.0

3.9

—

148

(3020650) Glucose [Presence] in Urine

2.15

1.61

1.1

1.6

—

(4306422)

337

1.43

1.59

1.3

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

543

1.34

1.57

3.1

2.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

692

1.30

1.57

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

314

1.44

1.55

1.4

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

145

1.66

1.54

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

315

1.44

1.52

1.4

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

582

1.31

1.50

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

127

0.39

1.49

1.2

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

101

1.79

1.48

1.1

2.1

160.5

154.6

0.09

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

167

0.48

1.46

1.0

ng/l

751.3

690.5

—

105

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

168

0.47

1.46

1.0

ng/l

414.0

315.9

—

109

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

169

0.47

1.46

1.0

ng/l

58.0

45.2

—

108

(3000330) Specific gravity of Urine by Test strip

136

1123

1.22

1.46

5.1

3.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.13

1.44

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.92

1.43

1.3

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

2.73

1.43

1.5

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

227

0.53

1.43

2.3

1.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.79

1.43

3.3

2.4

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.82

1.41

1.4

2.2

ug/l

16.6

108.0

0.50

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

136

1630

0.83

1.40

1.5

1.8

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.25

1.40

2.6

3.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

158

1.59

1.37

1.0

1.1

—

(3000492) Spirometry study

184

2141

0.85

1.36

1.7

1.5

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.94

1.36

1.4

1.1

—

(4094501)

637

0.73

1.32

1.0

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

217

1.48

1.30

2.1

1.4

40.9

32.3

0.48

130

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

217

1.48

1.30

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.78

1.28

1.0

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.00

1.27

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

559

5178

1.10

1.24

5.0

3.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2411

23816

1.15

1.21

28.3

10.7

u/l

26.5

25.9

1.04

2386

22979

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.80

1.21

1.1

1.4

umol/l

1.8

4.2

4.17

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.84

1.19

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.75

1.19

2.5

2.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.31

1.18

1.0

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.50

1.15

1.6

2.4

—

(3001729) Color of Synovial fluid

2.50

1.15

1.2

1.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

366

0.68

1.12

1.0

1.1

iu/ml

25.8

1589.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

151

1296

1.18

1.12

2.4

2.2

nmol/l

11.1

12.7

1.57

136

1138

(3005322) IgE [Units/volume] in Serum or Plasma

162

1400

1.17

1.11

1.3

u/ml

297.8

202.4

0.37

140

1290

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

208

1832

1.15

1.11

3.0

2.9

ng/l

163.1

181.9

0.36

192

1654

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.78

1.10

1.1

2.3

199.5

166.3

0.48

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

182

0.55

1.10

1.7

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

340

0.67

1.09

1.1

u/ml

6.9

1.7

0.49

140

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

346

1.34

1.09

1.3

1.2

u/ml

1.4

3.3

1.21

103

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.38

1.09

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1122

0.82

1.08

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

278

1.37

1.07

1.5

1.4

pmol/l

834.1

296.5

0.62

217

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

400

1.31

1.07

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

365

1.32

1.06

1.2

u/l

152.3

37.5

2.53

313

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.79

1.04

1.5

1.9

ug/l

0.5

1.3

1.78

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

154

1.50

1.03

1.1

1.2

mmol/l

11.4

11.9

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.96

1.03

5.4

3.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

590

1.24

1.02

1.1

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.88

1.00

1.4

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.18

0.98

1.2

1.5

—

(3044009) aPTT.lupus sensitive (LA screen)

2.18

0.98

1.0

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

148

1.49

0.98

2.6

2.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.95

0.97

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.63

0.97

1.0

—

(3004775) Volume in Urine collected for unspecified duration

191

1.42

0.94

2.2

788.1

636.0

1.08

130

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

338

1.31

0.94

1.2

1.1

—

(40768443) Skin Pathology biopsy report

115

984

1.18

0.93

1.2

—

(3025130) Human papilloma virus identified in Specimen

292

0.68

0.92

1.5

1.8

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.07

0.89

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.07

0.89

1.2

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

185

1.41

0.89

1.7

2.1

u/field

1.5

2.1

0.57

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

0.87

1.0

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

299

0.70

0.86

3.2

2.3

mg/l

46.6

24.6

—

(3038515) Glucose [Moles/volume] in Venous blood

441

1.25

0.86

4.9

3.2

mmol/l

7.1

7.5

0.64

427

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

0.85

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.94

0.84

1.2

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

467

0.77

0.83

4.0

1.9

nmol/l

1.1

0.8

0.96

382

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

273

0.69

0.83

1.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.74

0.82

1.0

1.2

—

(3021788) Differential panel - Synovial fluid

417

1.25

0.82

2.0

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

267

1.32

0.81

1.5

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

545

1.22

0.80

5.8

4.2

—

(3028707) Methadone [Presence] in Urine by Screen method

259

1.32

0.79

6.8

2.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

114

1.49

0.79

1.3

1.2

—

(3023410) Appearance of Cerebral spinal fluid

233

1.33

0.79

3.5

1.5

—

(3000285) Sodium [Moles/volume] in Blood

1.82

0.79

1.3

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.79

0.0

1.2

—

640.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

814

1.17

0.78

1.5

1.4

—

(4198724)

1.67

0.78

1.2

1.8

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.78

0.0

1.8

—

44.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.53

0.78

1.0

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

115

1.48

0.76

2.1

1.3

4.0

4.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.77

0.76

1.2

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.64

0.75

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.64

0.75

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.09

0.74

1.0

—

(3036603) Volume of Urine

158

1.40

0.74

1.3

1.4

1821.3

1942.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

236

1.32

0.74

3.5

3.9

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

266

0.71

0.73

1.1

1.0

u/ml

1.1

2.4

—

(3019174) dRVVT (LA screen)

2.00

0.72

1.0

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

109

0.55

0.72

12.8

13.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

101

1.49

0.70

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

485

1.20

0.66

1.2

u/ml

7.9

4.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

105

1190

0.88

0.64

2.2

2.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

120

1.42

0.64

1.5

1.4

umol/l

24.0

23.9

0.00

113

(3048689) Calprotectin [Mass/mass] in Stool

288

2678

1.08

0.64

3.2

2.2

ug/g

216.9

131.0

2.38

239

2122

(44806071)

1.73

0.64

1.4

1.1

—

(3045424) Erythrocytes [Presence] in Urine

405

1.21

0.63

1.6

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

208

1.30

0.62

3.4

2.9

mg/l

46.4

31.4

0.29

147

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

131

1.38

0.59

1.1

u/l

1.2

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

123

1.38

0.57

1.6

1.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

173

0.69

0.57

2.3

1.5

g/l

0.8

1.0

1.43

173

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.67

0.56

1.0

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

393

1.20

0.56

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.54

0.55

1.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.58

0.54

12.3

12.4

mmol/l

4.2

5.9

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.58

0.54

1.0

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

126

0.63

0.54

2.0

1.5

ug/l

14.4

8.8

—

109

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

853

0.88

0.52

1.6

—

(4034850)

721

0.87

0.48

12.6

9.5

—

(3008898) HLA-B27 [Presence]

752

0.87

0.48

1.0

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1374

13477

1.04

0.47

3.3

2.8

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

211

0.76

0.47

1.1

u/ml

1.4

3.8

—

(3014271) Vancomycin [Susceptibility]

102

1.37

0.47

2.4

2.8

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.47

0.47

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

138

1.31

0.45

2.3

1.5

u/l

8.0

6.8

0.18

118

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

602

1.13

0.43

1.2

u/ml

4.3

3.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

229

0.78

0.42

1.1

1.0

u/ml

4.3

2.9

—

(40768800) Prostate Pathology biopsy report

392

0.84

0.42

1.1

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.41

0.0

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

2.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.0

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

123

1.30

0.40

1.3

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

141

1519

0.92

0.39

1.1

1.2

iu/ml

125.9

152.8

0.44

586

(3027456) Digoxin [Moles/volume] in Serum or Plasma

428

1.15

0.39

3.2

nmol/l

1.0

0.8

0.59

335

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

169

1.24

0.38

1.5

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

169

1.24

0.38

1.5

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

169

1.24

0.38

1.5

1.2

—

(4211845)

112

0.71

0.37

2.4

3.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

393

3776

1.05

0.36

1.5

1.4

—

(3044941) Cell count panel - Synovial fluid

375

0.85

0.36

1.4

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

611

1.12

0.36

1.2

u/ml

18.3

7.4

0.49

107

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

171

1.23

0.35

1.5

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

171

1.23

0.35

1.5

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

171

1.23

0.35

1.5

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

125

0.72

0.35

1.2

1.3

nmol/l

121.6

137.9

—

125

(4268621)

233

0.81

0.34

2.6

2.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

341

1.15

0.32

1.3

1.2

u/ml

2.7

4.9

1.28

139

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

296

2837

1.05

0.32

17.6

6.8

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

137

1.24

0.32

1.1

iu/ml

12.2

12.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

935

0.92

0.32

1.5

1.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

618

1.10

0.31

1.6

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

196

0.82

0.30

2.3

1.6

—

(4015189)

1.27

0.27

2.9

2.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

451

1.11

0.27

5.1

2.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

122

1.23

0.27

1.0

—

(3024928) Oxygen saturation in Venous blood

471

1.11

0.26

3.8

2.9

—

(3034426) Prothrombin time (PT)

1.25

0.25

1.1

1.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

114

1.23

0.25

1.5

1.3

mmol/l

7.0

6.0

0.64

107

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

0.73

0.24

6.3

2.8

umol/l

24.2

30.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.32

0.23

1.0

—

(3002619) Bacteria identified in Specimen by Culture

1.28

0.23

1.0

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

333

1.11

0.22

1.0

1.1

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.21

0.0

4.3

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.2

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3006462) Nitrate [Presence] in Urine

103

0.78

0.21

2.4

3.3

—

(3005570) Glucose [Moles/volume] in Urine

230

0.87

0.21

1.9

2.0

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

0.21

0.0

3.6

—

41.7

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

229

0.87

0.20

2.5

4.8

u/ml

169.8

65.4

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.18

0.19

2.5

3.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.13

0.18

11.0

8.8

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

172

1785

0.96

0.18

1.3

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

1.11

0.17

1.1

1.0

—

(44806420)

0.76

0.17

1.6

2.4

—

(4024509)

236

0.89

0.16

1.7

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

130

1.15

0.15

1.2

1.3

—

67.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.77

0.15

2.5

1.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.77

0.15

2.0

1.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.14

0.15

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

391

1.08

0.14

4.2

2.9

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

656

1.05

0.13

1.2

u/ml

28.4

34.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

335

1.08

0.13

1.1

1.3

—

(3015183) Erythrocyte sedimentation rate

109

0.83

0.13

1.0

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

256

2507

1.02

0.12

1.9

1.8

1.5

0.08

218

2191

(21491868) Cryoglobulin [Mass/volume] in Serum

1.16

0.11

1.4

1.3

—

0.3

—

(3028300) Cannabinoids [Presence] in Urine

582

1.05

0.11

4.6

2.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

918

9257

0.99

0.11

1.9

2.0

pmol/l

90.6

95.7

2.63

567

4683

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

553

1.05

0.11

2.9

2.4

ug/min

157.3

110.0

0.44

337

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.09

0.09

1.0

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

727

0.96

0.09

1.3

1.7

—

(3016879) Cocaine [Presence] in Urine

536

1.05

0.09

4.8

2.1

—

(3000764) Benzodiazepines [Presence] in Urine

577

1.04

0.08

4.5

2.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

302

1.06

0.08

1.8

1.3

nmol/l

—

(3003129) Base excess in Capillary blood by calculation

1.03

0.08

3.0

1.6

mmol/l

2.4

1.0

—

(3049717) Cytology report of Urine Cyto stain

874

1.03

0.08

3.0

2.5

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

0.78

0.08

1.2

pmol/l

164.8

276.3

—

(3024263) Appearance of Synovial fluid

117

1.11

0.08

1.6

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

483

4877

0.99

0.07

1.3

u/ml

1.1

1.6

0.62

142

1294

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

356

0.95

0.06

2.0

1.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

138

1.09

0.06

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

227

1.06

0.06

1.3

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

318

1.04

0.04

1.8

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1745

17476

1.00

0.03

4.6

4.2

pmol/l

14.9

14.8

0.80

1617

15902

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

591

0.98

0.02

1.1

u/ml

6.0

4.8

—

(3004616) Nuclear Ab [Presence] in Serum

292

1.03

0.02

1.3

1.2

—

(3027008) Opiates [Presence] in Urine

581

1.02

0.02

4.5

2.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

177

0.96

0.01

1.4

2.1

umol/l

18.1

6.1

—

121

(3027944) Amphetamines [Presence] in Urine

572

1.01

0.01

4.6

1.9

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

477

0.99

0.01

1.3

1.2

u/ml

68.3

48.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

106

0.94

0.01

2.1

2.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

116

0.95

0.00

1.1

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

154

1.04

0.00

2.6

6.5

—

(3044927) Protein electrophoresis panel - Urine

236

0.97

0.00

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

296

0.98

0.00

1.1

1.0

u/ml

2.8

2.5

—

120

(3047007) Chlamydophila sp Ab [Presence] in Serum

324

1.02

0.00

1.0

1.2

—

(3017704) Immunofixation for Urine

141

0.99

0.00

2.1

1.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

159

1.01

0.00

1.8

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

685

0.99

0.00

1.9

1.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

569

1.00

0.00

1.9

1.7

e6/l

16197.0

11626.9

0.32

415

(3011648) Oxygen content in Venous blood

176

1.02

0.00

2.3

1.9

8.5

11.1

1.75

176

(44813793)

148

1.01

0.00

1.1

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

5.6

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

255.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.02

0.00

8.6

9.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

740

1.00

0.00

1.6

1.5

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1308.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3022689) Creatine [Moles/volume] in Urine

0.87

0.00

1.7

1.5

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

8.0

—

74.8

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.6

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

3.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.5

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint DRUGADVERS_NEUTROPENIA and mortality.

Females

Parameter	HR [95% CI]	p-value
DRUGADVERS_NEUTROPENIA	8.726 [7.5, 10.15]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.057

During the follow-up period (1.1.1998 — 31.12.2019), 2730 out of 6944 females with DRUGADVERS_NEUTROPENIA died.

Males

Parameter	HR [95% CI]	p-value
DRUGADVERS_NEUTROPENIA	9.331 [7.49, 11.63]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.013

During the follow-up period (1.1.1998 — 31.12.2019), 2303 out of 4090 males with DRUGADVERS_NEUTROPENIA died.

Mortality risk

Mortality risk for people of age

years, who have DRUGADVERS_NEUTROPENIA.

N-year risk	Females	Males
1	0.721%	1.851%
5	4.66%	10.622%
10	11.24%	23.446%
15	20.101%	40.366%
20	32.103%	60.541%

Relationships between endpoints

↥

Index endpoint: DRUGADVERS_NEUTROPENIA – Drug-induced neutropenia

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Drug-induced neutropenia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints